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Abstract
A METHOD FOR PREDICTING DOSE CHANGES FOR HN TREATMENT USING SURFACE IMAGING
By Sarah Elizabeth Holler, B.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2022
Director: Dr. Christopher Guy, Assistant Professor, Department of Radiation Oncology
Head and neck cancer (HNC) is commonly treated with radiation therapy. A
conventionally fractionated radiotherapy treatment course for HNC lasts six to seven weeks,
and during this time, the patient’s anatomy may change substantially. The tumor and organs at
risk may all reduce in volume, and patients often experience weight loss due to side effects of
radiation such as xerostomia, dysphagia, and loss of taste. Anatomical changes lead to a
reduction in treatment quality due to decreased setup reproducibility and altered dose
deposition compared to the original plan. This may necessitate a mid-course resimulation and
replan; however, few clinics have developed a standardized method for determining if patients
need replanning, which may lead to overlooking patients who need it or wasting resources on
patients who do not. This work investigates a new method for determining when to resimulate
and replan HNC patients by utilizing their topographic anatomical changes to predict
differences in planned versus delivered dose distributions.
The first part of this work presents a method for deformable image registration of CT to
CBCT, developed using 15 retrospectively selected HN patients, which addresses the challenges
of inaccurate Hounsfield units and truncated field of view present in the CBCT. The registration
method was validated on 10 additional HN patients using contour comparison, with average
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DSC of 0.82, 0.74, 0.72, and 0.69 for the mandible, cord, and left and right parotid. This is
comparable to previous results found in the literature. The registration method was then used
to generate dose maps and surface contours for 47 patients for the second part of this work.
The second part of this work involved the development of a U-Net which takes the
original dose distribution, the original surface, and the treatment day surface as input and
predicts the treatment day dose distribution as output. Each of the 47 patients had three
deformed CTs evenly spread throughout the treatment course for the generation of treatment
day surface and dose, resulting in 141 data sets for training and testing of the network. The
network training was performed with 135 of these data sets, while the remaining 6 were used
for testing. The average RMSE and MAE between the true and predicted dose distributions for
the 6 test cases was 4.25 and 2.15.
The deformable image registration method was successful at producing reasonable
deformations between CT and CBCT for the purpose of dose-of-the-day calculation. This work
proved feasibility of the dose prediction neural network and shows promise for future clinical
applicability.
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Chapter 1 Introduction
The introductory chapter of this thesis presents the purpose of this work and
background information relevant to it.
As oncology advances, treatments are becoming more and more customized to
individual patients, with the goal of minimizing side effects while effectively killing cancer cells.
This is especially important in radiation oncology, where the lines between effective treatment
and not eradicating the cancer or causing lethal toxicity can be razor thin. In the head and neck
(HN) region, delivery of excessive dose to the organs at risk (OARs) can result in severely
decreased quality of life (QOL) due to dry mouth, loss of taste, and difficulty swallowing, among
other symptoms1–4. On the other hand, underdosing the tumor can leave the door open for
failed treatment, metastasis, or recurrence. While more complex treatments such as intensity
modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) have
improved both outcomes and side effects, there is still progress to be made in the form of
adaptive radiation therapy (ART). ART seeks to adapt treatments mid-course to account for
anatomic changes which affect dose deposition. This thesis describes the exploration of neural
networks as a tool for more efficient, data-guided ART, specifically for HN cases. The eventual
goal of this work is to have a fully-fledged clinical tool which radiation oncologists could use to
quickly and easily determine when a treatment adaptation is necessary.
This work uses computed tomography (CT) and cone beam computed tomography
(CBCT) images from pre-treatment and three mid-treatment time points to generate estimated
dose distributions and external body surfaces. The neural network is trained, tested, and
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validated on the generated data. This is the first work of its kind to use surface information via
neural network as a means to predict dose distributions.

1.1 Head and Neck Cancer
Head and neck cancer (HNC) was the seventh most common cancer globally and
accounted for 3% of all cancer incidence and 1.5% of all cancer deaths in the US in 2018, with
lip and oral cancer specifically contributing more deaths than any other HN site5,6. HNC
encompasses a number of primary cancer sites within the region, often arising from the
squamous cells of mucus membranes. They can be split into regions within HN: oral cavity,
sinonasal cavity, pharynx, nasopharynx, and larynx. While in the past, tobacco and alcohol have
been the leading cause of HNC, tied to 75% of cases at one point, human papillomavirus (HPV)
has since become the leading cause, now accounting for over 70% of HNC7.
In the tumor-node-metastasis (TNM) staging system, HNC tumors are staged by tumor
size and/or location, lymph node involvement, and presence of metastases. Tumor
characteristics are designated as Tis (for in situ), T1, T2, T3, T4a, and T4b, with some variation
depending on disease site, and increasing numbers indicating increasing tumor size and spread;
nodal involvement has similar designations and similar variations with disease site. Distant
metastasis is indicated by M0 for no distant metastasis and M1 if distant metastasis is present.
Each of the three scores contributes to determination of the overall stage of disease. For
example, an oral cavity mass measured between 2 and 4 cm in its largest dimension, with
involvement of a single same-sided lymph node, and no distant metastasis, would be
designated as T2, N1, and M0, and diagnosed as Stage III. For oropharynx cases, HPV status
must be determined as well. HPV-positive patients have a more favorable prognosis, as HPV15

mediated cancers tend to have better treatment response and HPV-positive patients tend to be
younger and fitter with fewer coexisting conditions than HPV-negative patients. Nodal
involvement is the greatest predictor of patient prognosis in HNC, and there are six nodal
groups commonly investigated by physicians: submental, upper, lower, and middle cervical,
posterior triangle of the neck, and supraclavicular. Metastasis is usually not seen until the late
stages of HNC, and generally occurs via the lymphatic system.
The primary curative modalities are surgery and radiation, although chemotherapy is
often used in conjunction. Radiation therapy may be used definitively or adjuvantly following
surgery, with or without chemotherapy, depending on tumor staging and location. Surgery or
radiotherapy alone are generally sufficient to cure Stage I and II disease, which accounts for 3040% of HNC patients. Surgical removal of lymph nodes or prophylactic radiation of the neck
may be considered to reduce chances of recurrence or further spread. For the more than 60%
of cases who present with Stage III or IV disease, multimodality treatment is used to increase
chances of survival while attempting to preserve function and quality of life. Survival rates for
locally advanced disease are less than 50% at five years. Survival rates for HNC are generally
better than cancers of different anatomic origin, due to the tendency of tumors in this region to
spread locally, as opposed to distantly. However, side effects of treatment are of great concern,
especially as the population of HNC survivors trends younger.

1.2 Current Practice of Head and Neck Radiotherapy
Radiation therapy (RT) of HNC is commonly used definitively, pre- or post-operatively,
and/or in conjunction with chemotherapy. Treatment techniques have evolved over the years,
from simple 2D or 3D conventional treatments to three-dimensional conformal radiotherapy
16

(3DCRT) to intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy
(VMAT), made possible by improvements in imaging and beam delivery. Conventional
treatments use relatively few beams shaped by jaws, often requiring decisions to be made
about sacrificing normal tissue function. 3DCRT uses forward planning, where the number of
beams and their parameters are chosen iteratively as planning goals are assessed after beams
have been designed or adjusted, and multiple beams made by static multi-leaf collimators
(MLC) shapes to conform to the target. IMRT uses inverse planning and beams modulated by
MLCs to conform the dose to the target even further. In inverse planning, the TPS generates a
fluence map to meet predefined planning goals, and then beam parameters and MLC positions
are computed to achieve the desired fluence. The modulation may be achieved via a step-andshoot (static) delivery technique, where the field is divided into segments and the beam is off
while the leaves move to form the different beam shapes, or a sliding window (dynamic)
delivery technique, where radiation is delivered while the leaves migrate and the timing of the
movements determine the intensity of the radiation. VMAT is an extension of IMRT where
radiation is delivered while the gantry and the MLCs simultaneously move, with varying speeds
and dose rates. 3DCRT, IMRT, and VMAT are markedly better than 2D conventional techniques
due to the ability to shape the beams (3DCRT) or dose (IMRT and VMAT) to the target, thereby
sparing the surrounding normal tissues. Studies and systematic reviews of literature have also
demonstrated that IMRT and VMAT may further improve acute and late toxicities over 3DCRT,
with equivalent or better tumor control and survival8–11.
When RT is prescribed for a patient’s treatment using these advanced treatment
techniques, they must first undergo a treatment simulation. During simulation, the patient is
17

oriented on the CT scanner table in the position planned for treatment, using the indicated
immobilization devices. The planning CT (pCT) scan is taken at simulation with all devices in
place. The primary immobilization device for HNC is a thermoplastic mask, which covers the
head and may extend past the shoulders (Fig 1.1). This mesh-like mask is malleable while warm
and molds to the patient’s anatomy. As it cools, the mask hardens. This same mask is used
throughout the patient’s treatment course to reproduce the simulation position and minimize
intra-fraction motion. Minimizing inter- and intra-fraction motion, enabled by properly fitted
immobilization devices alongside proper inter- and intra-fraction imaging and monitoring,
allows smaller PTV margins and accurate delivery of the planned dose distribution while
avoiding potential geometric miss, which is critical to avoid underdosing of the target or
overdosing of normal tissue. In the case of a mask which does not cover the shoulders, straps
may be equipped to pull the patient’s shoulders down.

Fig. 1.1 Thermoplastic mask used for immobilization for HNC radiotherapy.

18

A treatment plan is designed based on the pCT by a dosimetrist or physicist in
conjunction with the physician; one to two weeks after simulation, the patient begins
treatment. For HNC, it is common to use a simultaneous integrated boost (SIB) treatment plan
for patients being treated definitively with radiation. An alternative method, sequential boost,
involves delivering a “boost” to the tumor volume following delivery of a 3DCRT or IMRT
treatment course; however, SIB has been found to achieve superior conformality, potentially
significantly reducing doses to OARs12,13. SIB plans often consist of a high-risk target receiving
70 Gy, an intermediate risk target receiving 60 Gy, and a low risk target receiving 54 Gy (Fig.
1.2). Prescriptions for post-operative patients are lower, with the high-risk target receiving 6066 Gy14. When designing the patient’s treatment plan, the physician draws the gross target
volume (GTV) contour around the bulky disease visible on imaging. An expansion is applied to
account for microscopic spread of disease beyond what is visible on available imaging, resulting
in the clinical target volume (CTV). A second expansion is utilized to account for random and
systematic setup errors, resulting in the planning target volume (PTV), to which the physician
prescribes dose. A typical prescription calls for 95% of the PTV to receive the prescription dose,
while not exceeding a maximum dose of 115% of the prescription dose. As mentioned
previously, in the case of SIB, each PTV in the set is designated as either high-, intermediate-,
and low-risk. High-risk PTVs typically include the primary disease, intermediate PTVs include
regional microscopic spread, and low-risk PTVs include the electively treated lymph nodes in
the neck. In addition to being optimized on the targets, the treatment plan must spare OARs as
much as possible and adhere to standardized dose constraints to avoid severe toxicities. For
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HNC, critical OARs include the parotid glands, spinal cord, brainstem, and mandible, whose
constraints are listed in Table 1.1.
Table 1.1 Critical OARs in HNC
Structure

Constraint

Endpoint

Parotid gland

Mean dose < 26 Gy

Reduced salivary function

Spinal Cord

Max dose < 45 Gy
(< 40 Gy if achievable)

Myelopathy

Spinal Cord +5mm

Max dose < 50 Gy

Brainstem

Max dose < 54 Gy

Neuropathy or necrosis

Mandible

Max dose < 70 Gy

Osteoradionecrosis

Fig. 1.2 Planning CT for SIB treatment with high-risk PTV indicated in red, intermediate-risk
PTV indicated in magenta, and low-risk PTV indicated in lime.
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This treatment scheme is generally delivered in 33 treatment sessions, called fractions,
of 2.12/1.82/1.64 Gy each, 5 days per week for 7 weeks. At each fraction, kilovoltage (kV)
orthogonal images or cone-beam computed tomography (CBCT) scans can be used to verify
patient setup. One strategy for pre-treatment imaging for HNC patients is to image daily with
orthogonal kV images and weekly with CBCT. The bony anatomy contained in kV orthogonal
images is only a surrogate for the soft tissue position but sufficient for treatment alignment on
a daily basis (Fig. 1.3). CBCT provides better soft tissue contrast for visualization of the external
surface of the patient as well as the gross disease and can be used to monitor anatomical
changes during the course of radiotherapy (Fig. 1.4). However, CBCT possesses its own unique
set of flaws which limit its use to setup imaging. Unlike CT, the FOV is truncated and the HU
values acquired by CBCT are inaccurate, making it challenging to use for dose calculation. These
challenges will be expanded upon in Chapters 2 and 3.

Fig. 1.3 Orthogonal kV images taken during HN RT.

Throughout the course of treatment, the patient’s anatomy is known to change. Some
change is intended, specifically tumor volume shrinkage; targets have been observed to shrink
21

by over 3%/week15–21. Other changes are undesirable side effects of normal tissue resulting
from the radiation treatment. The parotid glands have been observed to shrink by up to 21.3%
over the course of treatment, though these changes vary from patient to patient, and the
ipsilateral parotid gland generally shrinks more than the contralateral22. Both target and parotid
shrinkage are associated with cell death and vascular damage due to radiation. Additionally,
patients may lose weight due to side effects such as xerostomia, dysphagia, and loss of taste.
Anatomical changes significantly affect the delivered dose distribution to the targets and OARs,
resulting in differences from the original treatment plan.
Upon inspection of the pre-treatment volumetric imaging, the physician may decide that
the patient’s anatomy differs significantly from the anatomy within the pCT. In such cases, the
physician may order a new simulation and subsequent treatment plan to be used for the
remaining treatment fractions. This may also occur if there is increased difficulty setting up the
patient for treatment due to anatomical changes and ill-fitting immobilization devices often
caused by patient weight loss. After ordering a resimulation, the physician may elect either to
continue treatment with the original plan until the new plan is ready or to hold treatment until
the new plan is ready. This means that while the new plan is being prepared, the patient is
either receiving potentially suboptimal treatment or not receiving any treatment, both of which
may negatively affect the patient’s outcomes and toxicities. Multiple studies have found that
hot spots increased, while coverage of the PTV suffered, and the OARs received higher doses
when patients lost significant weight during treatment and were not replanned 16,23–27.
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Fig. 1.4 CBCT images (green) taken over the course of HN RT registered with the pCT
(magenta).

1.3 Adaptive Therapy Strategies
Adaptive therapy is the practice of changing a patient’s treatment plan due to anatomic
or biologic factors during the treatment course. This can occur in three different ways: offline
adaptation, online adaptation, and intrafraction adaptation. Intrafraction adaptation seeks to
address changes in the patient anatomy on the order of seconds, which may be a result of
breathing motion or other bodily functions. Online adaptation and offline adaptation are similar
to each other in that they both result in the generation of an entirely new treatment plan.
However, online adaptation is done at the treatment machine with the patient on the table.
This is commonly done on linacs with additional imaging capabilities, such as magnetic
resonance imaging (MRI) or CT-on-rails, where high quality images of the patient can be
captured each treatment day. However, some studies have sought to develop artificial
intelligence methods for online adaptation using CBCT to generate new contours and plans,
with demonstration of feasibility for the process28,29. Offline adaptation is done between
treatment fractions and may include repeat simulation if onboard imaging is not sufficient for
planning. Various adaptive planning methods have been explored for many anatomical sites,
23

including HN, lung, liver, and prostate30–33. Regardless of the site, it has been demonstrated
that adaptive therapy, when executed on the right patients at the proper time, results in
improved target coverage and reduced dose to the OARs. Any adaptive therapy method
requires careful planning to avoid disruption to the clinic and establish an efficient workflow,
given the resources required for adaptation.
The process of replanning is known to be time-consuming, taking multiple days to
produce a new plan24,34,35. Though there is no current standard method for HNC ART, individual
clinics have executed a variety of methods to standardize this process to only replan the
patients who benefit most24. One study used a nomogram to predict parotid gland overdose,
using the planning CT and a CT from the first treatment week to obtain the volume of the CTV
planned to receive 70Gy, the difference between that volume in the pCT and the second CT,
and the mean parotid gland dose difference between the pCT and the second CT; the
nomogram correctly predicted patients who would have a >2.5 Gy overdose to the parotid
glands, indicating they would benefit from weekly adaptive planning36. Another study
developed a patient selection method based on multivariate linear regression which could
theoretically predict, based solely on pre-treatment parameters, which patients would benefit
most from adaptive therapy; a separate study used similar parameters to create a decision
tree37,38. Brown et al. simply used pre-treatment nodal size to determine patients more likely to
need a replan; in other work, the same authors determined more specifically that nasopharynx
cancer (NPC) patients with large nodes may require replanning at week 3 of treatment, while
oropharynx cancer (OPC) patients with large nodes may require replanning at week 4 of
treatment39,40. Deformable image registration (DIR) between the planning CT and the daily
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CBCT has also been used to recalculate the dose at each fraction, leading to fewer unnecessary
replans and no missed cases, though this was a small study41. Other studies have indicated that
adaptive planning is more effective in definitive treatments than in adjuvant treatments, which
could help with patient selection42. Brown et al. also investigated virally mediated HNC (Epstein
Barr positive or HPV positive), as these cancers are known to be highly responsive to
radiotherapy, and found that those who presented with larger nodes were at a higher risk for
needing replanning43.
Many studies use pretreatment indicators of risk for needing a replan, which can be less
accurate and predictive than desired. Relying on daily DIR to assess dosimetric changes, while
more accurate, is time-consuming and may not be feasible in the average clinic. However,
multiple studies note significant benefit to patients who have been properly selected for
adaptive therapy. Reduced dose to OARs, improved target coverage, reduced toxicities, and
improved overall survival and locoregional control have all been seen in various studies 16,27,44–
51.

1.4 Surface Imaging in Radiotherapy
Surface imaging is a non-radiographic imaging technique used in RT to guide setup and
treatment in much the same way as its radiographic counterparts, without the ionizing
radiation. There are several different commercially available surface imaging systems, all
operating with similar methodology. Systems compare a reference surface of the patient to a
surface obtained in real time during treatment and report deviations in the form of error bars
on 6 degrees of freedom (DOF). One surface imaging system is AlignRT (VisionRT, London,
United Kingdom), with three camera and projector pods so the patient can be imaged
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regardless of gantry angle (Fig. 1.5). The reference surface is either extracted from a userselected contour associated with the pCT (i.e. the body contour) or acquired in the treatment
room by the system. Surfaces are described by vertices and triangular faces, and the density of
points used for surface definition varies according to software settings. The comparison surface
is the patient’s surface as they are immobilized on the treatment table. The projectors cast
visible light that is colored red and in the form of a pseudo-random speckled pattern onto the
patient’s body. Optical cameras use the observed textural pattern and triangulation to create a
3D map of the patient surface52–55. The surface captured by the cameras may not include all of
the anatomy in the reference surface, since the cameras only capture the anterior surface of
the patient, if the patient is laying in a supine position on the treatment table. A rigid
registration algorithm compares the two surfaces within the user-defined region of interest
(ROI). Positioning uncertainty of AlignRT has been reported to be <1mm and <1°56. In a typical
clinical workflow, therapists will position the patient on the table with the appropriate
immobilization devices from simulation followed by the use of surface imaging to align the
patient more accurately and precisely before exiting the room and performing radiographic
imaging or starting treatment. Surface imaging may also be used to monitor the patient
throughout treatment, as it does not impart ionizing radiation dose to the patient.
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Fig. 1.5 Images demonstrating AlignRT System. A: Projection of red speckle pattern on
phantom. B: Software display depicting alignment of reference surface and real-time surface
along with error bars. C: Reference surface, generated from body contour. D: Real-time
surface obtained using AlignRT cameras.
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Surface imaging has a variety of applications in RT, including reducing margins for
targets and OARs by improving setup, improving patient comfort via removal of immobilization
devices, minimizing radiographic imaging dose, and allowing gating when breathing motion is
relevant to treatment52,57,58. It is particularly useful in regions where the surface is a good
surrogate for the treatment target, such as with the shallow targets seen in breast. Previously,
it has been investigated for and found use in treatment sites such as breast, accelerated partial
breast irradiation, chest wall, abdominal and pelvic sites, extremities, intracranial stereotactic
radiosurgery (SRS), and head and neck52,55. Of particular interest are SRS studies, where high
precision in positioning is especially critical. Surface imaging studies in SRS have used surface
imaging in place of the typical frame and mask system and found that with an open face mask
or no mask at all, similar precision could be achieved, and greater patient comfort was
possible58. Additionally, setup with surface imaging took significantly less time than the
conventional frame-based approach. In HN studies, patients were outfitted with open face
masks to reduce patient anxiety, and setup errors between closed and open face masks were
found to be comparable56,59–61. Open face masks also allow for more flexibility in using bite
blocks and may reduce the bolus effect that causes skin toxicity. All cited studies used the
patient surface as a surrogate for internal anatomy and were able to detect intrafraction
surface changes with reasonable accuracy, suggesting that surface imaging could be extended
to detect interfraction surface changes with similar accuracy.

1.5 Specific Aims
Given the known anatomic and dosimetric changes observed during a HNC patient’s
treatment course and the difficulty in determining the need for adaptive planning, the overall
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aim of this work was to develop a neural network to aid adaptive therapy decisions, using
machine learning capabilities to detect the effect of anatomic changes on the planned dose
distribution. In pursuit of that aim, it was necessary to develop a deformable image registration
workflow to handle the CT-CBCT registration task, which would enable weekly dose calculation
without altering the current clinical imaging strategy.
The hypothesis of this work is that changes in the patient’s surface can be used to
predict changes in the radiation dose distribution and therefore determine and inform the
treatment team of when re-simulation and re-planning should be considered to minimize
differences between the expected and the delivered dose distributions.
Specific Aim 1
To develop a methodology for creating a synthetic CT and calculating delivered dose during a
treatment course.
Specific Aim 1.1
To develop an approach for deformably registering a planning CT to a CBCT to address field of
view and artifact issues.
Specific Aim 1.2
To evaluate the accuracy of the synthetic CT creation on 10 new HN cases.
Specific Aim 1.3
To calculate delivered dose and quantitatively compare planned dose distribution with
delivered dose distribution in HN patients.
Specific Aim 2
To develop a tool that requires user input of patient surfaces and predicts changes in dose
distribution.
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Specific Aim 2.1
To create a neural network which uses initial patient surface, initial dose distribution, treatment
day surface, and treatment day dose distribution as training data.
Specific Aim 2.2
To evaluate the dose prediction network using dose statistics and a cohort of reserved cases.
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Chapter 2 Introduction to Deformable Image Registration
This chapter reviews the fundamentals of image registration as it relates to the work
presented in Chapter 3.

2.1 Image Registration
Image registration is the process of finding the geometric relationship between two
images. The purpose of image registration in RT may be to guide treatment planning or patient
setup or to simply provide additional information about a patient’s disease. Typical images used
in RT include (but are not limited to) CT, CBCT, magnetic resonance imaging (MRI), positron
emission tomography (PET), radiographs, and surface images. Apart from radiographs, which
are two-dimensional, the modalities listed here all produce three-dimensional image sets.
Image registration may be mono- or multi-modality. For instance, a patient being treated with
RT a second time in the same anatomical region would need mono-modality image registration
of the CTs from their first and second treatments to ensure appropriate sparing of OARs, while
a patient whose tumor is not well-visualized on CT may need multi-modality registration of
their CT with a PET or MRI for accurate target delineation. There are many aspects of image
registration to consider when attempting to register two images, but the most important are
the transformation model, the registration cost function, and the optimization procedure.
2.1.1 Transformation Model
Geometric transformations map points from one image space, X, to their corresponding
points in a second image space, Y62. A transformation T acts on a point x in X to produce a
transformed point x’ ϵ Y,
x’ = T(x),
(2.1)
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where x and x’ are column vectors. A successful registration results in x’ and y being equal if
point y in Y corresponds to x in X. A registration error is the existence of a displacement
between y and x’. Transformations can be divided into rigid and nonrigid transformations. Rigid
transformations preserve distances, straightness of lines, and angles, while deformable
transformations may not preserve any of these features as the deformation is allowed to vary
nonuniformly throughout the image volume.
Rigid transformations consist of translations and rotations, given by
x’ = Rx + t,
(2.2)

where the rotation is given by R, a 3x3 orthogonal matrix, and the translation is given by t, a
three-dimensional vector. In medical images, translations may occur in the superior-inferior,
anterior-posterior, and lateral directions, and the rotations may occur around those axes. These
transformations are useful when the object of interest is rigid anatomy, such as bones, or other
anatomy which maintains rigidity between images. The degrees of freedom, or number of
parameters, for the rigid transformation shown in equation 2.2 is 6, a rotation and translation
in each physical dimension.
To model deformable transformations, a significantly larger number of degrees of
freedom are necessary than for rigid transformations. At the extreme, an independent
translation for each voxel of the fixed image can be calculated, equating to 3 x n voxels in
degrees of freedom in a 3D image. Not only is such a transformation model computationally
prohibitive, but also medical images deal with anatomy of patients which does not deform with
enough complexity to require such a free-form transformation model. Instead, deformable
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transformations are parameterized to a much smaller number of degrees of freedom. This not
only speeds up the registration algorithm, but also enforces certain properties on the resulting
deformation.
A common parametric approach to deformable transformation is B-splines. B-splines are
a basis set of piecewise polynomials which define the space by dividing it into a set of
hexahedrons, whose corners are called knots or control points. The control points are arranged
on a regular grid over the fixed image, different from the voxel matrix of the image, and the
transformation of a single point can be calculated from only a couple of surrounding control
points. The equation for a B-spline transform is as follows:
𝑥 − 𝑥𝑘
𝑇𝜇 (𝑥) = 𝑥 + ∑ 𝑝𝑘 𝛽 3 (
)
𝜎
𝑥𝑘 ∈𝑁𝑥

(2.3)

where the control points are represented as xk,

β3(x)

represents the cubic B-spline polynomial,

pk represents the B-spline coefficient vectors, σ is the control point spacing, and Nx is the set of
all control points within the compact support of the B-spline. In this case, the degree of the Bspline, m, is 3, a common choice in DIR. If pk are chosen well, the transformation will be degree
m – 1 times continuously differentiable, ensuring the polynomials join smoothly across the
interfaces of the rectangles.
Importantly, the transformation maps points from the fixed (or target) image to the
moving (or source) image. This is referred to as backward mapping, where pixel values of voxels
in the deformed image are pulled from the moving image, and is preferred to forward mapping,
where pixel values of voxels in the moving image are pushed to the deformed image. Forward
mapping of deformable transformation results in needing to interpolate pixel values in the
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deformed image, since voxels in the moving image will not be an exact match to voxels in the
deformed image.
2.1.2 Objective Function
The registration objective function, or cost function, defines the criteria by which images
are matched. The objective function is often a linear combination of similarity metrics and
penalty terms which quantify the goodness of match resulting from a given deformation field.
The general form of this cost function is then:
𝐶(𝑇) = −𝑆(𝑇) + 𝛾𝑃(𝑇),
(2.4)

where C is the overall cost, S is the similarity metric, P is a penalty term, and 𝛾 is a weight to
control the effect of similarity versus regularity, all calculated on the transformation T. The two
main types of similarity metrics are geometric-base and intensity-based, and these may be used
in tandem as a hybrid cost function.
Geometric similarity metrics can take the form of point sets in each image; the aim of
the registration in this case is to align corresponding markers between images. These markers
may be drawn from the anatomy or may be implanted fiducials or some other extrinsic
landmark. The transformation aligns the markers as closely as possible, minimizing the
registration error between the points. However, the designation of the points is often not
perfect and will carry its own error, called fiducial localization error (FLE). In a constrained
problem such as rigid registration, aligning well-placed landmarks will result in minimal
registration error for other points. Yet in deformable transformations, the selection of
transformation model can greatly affect the accuracy of registration of non-landmark points.
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Intensity-based methods use the scalar values of pixels or voxels to inform
transformation. Under these methods, a similarity measure calculated over the pixel or voxel
values is optimized to determine the correct registration. The similarity measure should be
carefully selected to account for the properties of the images being registered and the
relationship between the intensity values found in the two images. An ideal similarity metric
returns low values when the same tissue types are being compared and high values when
differing tissue types are compared. With this in mind, similarity metrics can be divided based
on whether the registration is a mono-modal or multi-modal problem.
Mono-modal image registration involves two images of the same modality, i.e. CT-to-CT
registration. In this case, intensities from the same anatomical feature in both images are
expected to be equivalent or exhibit a linear relationship. If the intensities are equivalent, sum
of square differences or absolute differences (SSD or SAD) are acceptable similarity metrics. If a
linear relationship between intensities exists, the appropriate similarity metric would be cross
correlation or correlation coefficient.
In the case of multi-modality registration, images of different types are registered (i.e.
MR-to-CT). Anatomically-corresponding tissues often have intensities that are no longer
equivalent or even linearly related. To address this, information theoretic measures have been
employed. Of these, mutual information (MI) may be the most well-known. MI seeks to
minimize entropy between the resulting deformed image and the fixed image. One derivation
of mutual information begins with the joint histogram of two images. With two aligned images
A and B’, the joint histogram charts the intensities of each image. When the joint histogram is
normalized, the probability distribution function is obtained:
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𝑃𝐷𝐹[𝑗, 𝑘] =

𝐻𝐼𝑆𝑇[𝑗, 𝑘]
∑𝑗,𝑘 𝐻𝐼𝑆𝑇[𝑗, 𝑘]
(2.5)

where HIST is the joint histogram calculated for two images related by a transformation. Then,
the joint entropy H can be calculated using the PDF:

𝐻 = − ∑ 𝑃𝐷𝐹[𝑗, 𝑘] log 𝑃𝐷𝐹[𝑗, 𝑘]
𝑗,𝑘

(2.6)

MI, as opposed to entropy, takes into account the change in the histogram caused by
transformation. To calculate MI, one must calculate the marginal entropies H(A) and H(B’) as
well as the joint entropy H(A,B’):

𝐻(𝐴) = ∑(∑ 𝑃𝐷𝐹[𝑗, 𝑘] log ∑ 𝑃𝐷𝐹[𝑗, 𝑙])
𝑗

𝑘

𝑙

(2.7)

𝐻(𝐵′) = ∑(∑ 𝑃𝐷𝐹[𝑖, 𝑘] log ∑ 𝑃𝐷𝐹[𝑗, 𝑘])
𝑘

𝑖

𝑙

(2.8)

The MI equation then follows:
𝑀𝐼(𝐴, 𝐵 ′ ) = 𝐻(𝐴) + 𝐻(𝐵 ′ ) − 𝐻(𝐴, 𝐵 ′ ).
(2.9)

When the images are correctly aligned, entropy will be at its minimum and MI will be at its
maximum. However, it may be possible for the images to get misaligned and still end up with a
maximum in MI; therefore, MI is not overlap invariant. An extension of MI, called normalized
mutual information (NMI), was developed to solve this problem:

𝑁𝑀𝐼(𝐴, 𝐵 ′ ) =

𝐻(𝐴) + 𝐻(𝐵 ′ )
𝐻(𝐴, 𝐵 ′ )
(2.10)

However, it also has been demonstrated to not be overlap invariant. Other approaches have
been explored, but each has its drawbacks.
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Penalty terms, used to regularize transformations, are often calculated using the first or
second order spatial derivatives of the transformation and added to the cost function63.
Weights can be applied to both the similarity metric and the penalty term to control the effect
of one versus the other. Any penalty term can be used with any similarity metric, but bending
energy is potentially the most common form. The equation for the bending energy penalty term
in 2D is:
2

1
𝜕 2𝑇
Ƥ𝐵𝐸 (𝜇) = ∑ ‖
(𝑥̃ )‖
𝑃
𝜕𝑥𝜕𝑥 𝑇 𝑖 𝐹
𝑥̃𝑖

(2.11)

where 𝑥̃𝑖 are points over which the term is evaluated, and P is the number of these points. With
this penalty term applied, the cost function will increase with sharp gradients of the
transformation, such as high expansion abutting high compression, which reduces folding in the
transformation.
2.1.3 Optimization Methods
The goal of optimization is to find the optimal registration according to an objective
function, which is generally composed of a similarity metric and a regularization term
constraining the transformation. Optimization methods solve problems with variables that are
either continuous or discrete. Continuous optimization methods take the form:
𝜃𝑡+1 = 𝜃𝑡 + 𝛼𝑡 𝑔𝑡 (𝜃𝑡 )
(2.12)

where θ is the vector of transformation parameters, t indicates the iteration number, α t is the
step size, and g indicates the search direction. The search direction is determined using the
entire objective function. A commonly used continuous optimization method is gradient
descent, which follows the direction that decreases the cost function magnitude
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𝑔 = −∇𝜃 (𝜃)
(2.13)

However, a drawback of gradient descent and other deterministic gradient methods is the
computational demand of calculating derivative information due to the high dimensionality of
the data and search space. Instead, stochastic gradient descent uses an update formula which
approximates the gradient to reduce the computational demand. A specific application of
stochastic gradient descent developed by Robbins and Monro (RM) decreases the step-size with
time to decrease inaccuracy64.
Other optimization methods include the Quasi-Newton method, which uses secondorder information about the cost function to achieve better theoretical convergence than
gradient descent65. Another type of approach includes conjugate gradients, which can be used
to minimize quadratic or generally nonlinear cost functions, and can also achieve higher
precision. However, both of these approaches are computationally expensive and take far
longer to implement for minimal improvement in precision, which makes stochastic gradient
descent the preferred approach for many DIR problems.

2.2 Deformable Image Registration for CT-to-CBCT Registration
Deformable image registration is a valuable tool in radiotherapy, where its use ranges
from calculating composite treatment plan doses to using multiple modalities to improve target
and OAR delineation to automatic segmentation based on contour atlases. As outlined
previously, different tasks require different choices in transformation, similarity metric,
optimization method, and more. Each task also possesses its own unique challenges. CT-toCBCT registration has been explored for “dose of the day” calculation to assist in dose
monitoring as well as adaptive therapy66–69. While dense deformation field methods such as the
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viscous fluid method have been investigated, most studies use cubic B-splines and have found
them to be sufficient for CT-to-CBCT registration66,68–71. Many studies have used hybrid
similarity metrics, most commonly providing anatomical information in the form of contours
alongside an intensity measure, with some authors using selectively applied rigidity penalties as
well66,67. Commercial and open-source algorithms have both been tested, and target
registration errors in the range of 2-3 mm were reported66,67. However, the issue of the
reduced field of view of the CBCT has very rarely been addressed in DIR studies.

2.3 Challenges of CT-CBCT Deformable Image Registration
The first aim of this work seeks to address one of the principal problems in deforming a
pCT to a CBCT, which is the reduced FOV of the dCT stemming from using a truncated CBCT as
the fixed image. The pCT must be deformed to the CBCT to acquire both the correct HU and the
anatomy of the day to produce an accurate dose calculation for neural network input. However,
designating the pCT as the moving image and the CBCT as the fixed image in traditional DIR
applications results in the pCT being truncated to the smaller FOV of the CBCT to produce a
reasonable registration. The pCT has an array size of 512 x 512 and a typical voxel size of 1.17 x
1.17 x 3 mm3 (FOV 60 x 60 cm2) (Philips Brilliance Big Bore, Koninklijke Philips N.V., Amsterdam,
Netherlands). The CBCT array size is 512 x 512 with a typical voxel size of 0.511 x 0.511 x 1.99

mm3 (FOV 26.17 x 26.17 cm2) (Varian Truebeam, Varian Medical Systems, Palo Alto, CA, USA).
In HN cases, the reduced FOV results in missing anatomy superior and inferior of the CBCT as
well as in the posterior and lateral directions (Fig. 2.1). Radiation often passes through anatomy
not visible on the CBCT; replacing the missing information is crucial to an accurate dose of the
day calculation.
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Fig. 2.1 CBCT (left) and pCT (right) for an example patient, showcasing the reduced FOV and
image quality of the CBCT as compared to pCT. Arrows indicate regions of highest noise.
Choosing the correct similarity metric for DIR is imperative to obtaining accurate
registrations. CT and CBCT differ in both their geometry and reconstruction methods, resulting
in reduced image quality in CBCT (Fig. 2.1). While CT relies on a two-dimensional fan-beam
geometry and a curved detector, meaning that rays on the edge of the detector have traveled
approximately the same distance as rays at the center of the detector, CBCT uses a threedimensional cone-beam geometry and a flat detector. The cone-beam X-ray geometry and flat
detector results in a longer path-length from source to detector for rays on the periphery
compared to those in the center. Additionally, the Feldkamp algorithm (FDK) utilized for CBCT
reconstruction, an extension of the filtered backprojection algorithm (FBP) used in CT, makes
several approximations which limit its accuracy; however, the FDK algorithm does not require
significant computational resources to produce short reconstruction times, ensuring its
continued use. Most importantly, CBCT lacks the collimation of detectors present in CT to
reduce scatter contamination, which cannot be corrected through reconstruction algorithms.
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These differences between CT and CBCT result in reduced image quality and increased artifacts
in CBCT. Additionally, the image quality and artifacts are spatially variant, with image quality
degrading further from the central plane, similar to images produced with the FBP algorithm.
Due to this spatially variant difference in intensity between CT and CBCT, previous studies have
had limited success with intensity-based registration methods, unless an intensity correction
step is taken iteratively. This suggests that a mutual information metric may be better suited for
CT/CBCT DIR. This informed the development of the DIR method detailed in the next chapter.
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Chapter 3 Development of a Deformable Image Registration Method
for CT-CBCT Registration
This chapter summarizes the work performed to achieve specific aim 1 as outlined in
Chapter 1.5.

3.1 Initial Exploration
Initial work on the DIR method explored the use of a commercially available medical
image software (MIM v6.7.9, MIM Software Inc, Beachwood, OH) with DIR capabilities. At the
time, this DIR software possessed limited flexibility, allowing the user to choose between
“image-based” and “normalized image-based” deformation. The transformations are intensitybased, as the algorithm is designed for mono-modality registration. Both transformations were
tested on multiple patients to determine which transformation performed better for this
registration problem. The normalized deformation proved to be appropriate for CT-to-CBCT
registration, but the DIR module provided no solution to the truncated FOV issue. However,
MIM allows for the development of automated workflows with a wide range of capabilities, and
a workflow was created which could stitch together the smaller dCT with the larger pCT. The
workflow took the pCT and replaced all image data inside the FOV of the CBCT with the dCT
image data. Unfortunately, the joining of the two image sets was anatomically unrealistic and
left large gaps in the shoulders (Fig. 3.1A). These gaps could be manually masked out and filled
with soft tissue-equivalent HU values for adequate dose calculation, and investigation was
undertaken to streamline or automate that process. Ultimately, however, the inflexibilities of
this method resulted in the pursuit of a more adaptable method.
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Fig. 3.1 A: pCT-to-CBCT deformation and stitching as performed in MIM. B: The dCT
produced using elastix for the same image set. 1: axial view at the superior edge of the CBCT
FOV, 2: axial view near the inferior edge of the CBCT FOV, 3: coronal view.

3.2 Development of elastix-based method
The open-source DIR algorithm elastix was investigated as a potential solution
considering the drawbacks found with using a commercially available software. elastix is a
parametric registration software package which allows for maximum flexibility in choosing
parameters to create the best possible set of transform parameters for a given dataset63. While
investigating parameters for CT-to-CBCT registration, it was discovered that the FOV of the pCT
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could be preserved in the dCT by expanding the array size of the CBCT prior to registration. The
resulting dCTs were smooth, exhibiting none of the discontinuities or gaps of the image
replacement method used in MIM (Fig. 3.1B).
Fifteen HN patients with one pCT and three CBCTs each were retrospectively selected to
develop the overall method and specific elastix parameters (Table 3.1). Patient selection was
limited to those treated on Varian TrueBeam linacs (Varian Medical Systems, Palo Alto, CA), due
to the superior image quality of the onboard imager (OBI) relative to other image guided
radiotherapy (IGRT) systems available at our institution. Only patients with anatomic changes
visible on CBCT were chosen for development of the method (as shown in Fig. 1.4). Parameter
files were developed from an in-house registration parameter file and a previously published
deformable registration parameter file72.

Pt #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Sex
M
M
M
M
M
M
M
M
M
M
M
M
M
F
M

Table 3.1 Patient Demographics for DIR Development
Age
Disease Site
51 Larynx
58 Oropharynx
50 Oropharynx
47 Oropharynx
64 Oropharynx
63 Larynx
64 Neck
57 Oropharynx
68 Nasopharynx
71 Oropharynx
57 Oral cavity
62 Oropharynx
54 Oropharynx
47 Oropharynx
64 Oropharynx

44

Stage
T2N3
T2N1
T2N1
T1N3
T2Nx
T3N2b
T0N2c
T2N1M0
T4N2M0
T3N2
T3N1
T2N0M0
T3N2
T3N2c
T4a

The developed method used a combination of MATLAB (Mathworks, Natick, MA) and
elastix, an open-source DIR algorithm. The pCT and CBCT were exported from MIM in mhd
format. MATLAB scripts resampled and padded the CBCTs with air to the resolution and
approximate size of the corresponding pCTs (Fig. 3.2). Padding was performed symmetrically in
the anterior-posterior, left-right, and superior-inferior directions. Binary masks were also
created corresponding to the FOV of the CBCT to ensure the algorithm only uses information
inside the FOV for calculating the rigid and deformable registration. The mask was drawn sliceby-slice, creating circles with radius equal to half the width of the image, which were then
stacked to generate a cylindrical mask. The most superior and inferior 3 slices were omitted
from the mask entirely to avoid the decreasing FOV at the scan edges. Each registration was
completed in elastix which included a rigid transform followed by a B-spline transform.

Fig. 3.2 A: Original CBCT. B: Resampled and padded CBCT showing the expanded array. C:
Binary mask overlaid on resampled and padded CBCT. 1: Axial view. 2: Coronal view.
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Deformable registration was performed using a B-spline transformation basis, defined
by a uniform grid of control points overlaid on the fixed image (CBCT). Since a mask was used to
indicate the CBCT FOV as the region of interest, the cost function was only calculated from
sample points within the mask, and the deformation field smoothly decreased to zero across
the boundary. This meant the anatomical information outside of the CBCT FOV in the dCT was
not deformed but simply rigidly registered. The registration was performed with an anisotropic,
multi-resolution image pyramid, such that in each of the 3 resolutions used, the superiorinferior dimension had less downsampling to account for the larger spacing inherent to the
images. The deformable portion of the registration algorithm used a combination of mutual
information and a bending energy penalty term for the similarity metric and regularization
term, respectively. The bending energy penalty term penalizes abrupt changes in the
transformation, such as large compression abutting large expansion. This may prevent the
deformation from becoming irregular or folding in on itself. Weights for the two metrics were
optimized to improve performance on this dataset. During development, the registration
quality was assessed using the Jacobian map of the deformation vector field and visual
inspection. The determinant of the Jacobian can be used to determine whether a physically
possible deformation has occurred, while visual inspection ensures that bony anatomy and
patient surfaces are reasonably aligned. Negative values for the determinant of the Jacobian
indicate the deformation has folded in on itself (invalid); values between 1 and 0 indicate
reduction in volume, while values greater than one indicate expansion.
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Investigation of the Jacobian map revealed that mutual information alone was not
sufficient to generate acceptable deformations, as the resulting transformations exhibited
inaccurate and excessive deformation, including folding. The final parameters are listed in table
3.2.

Table 3.2 Rigid and Deformable Image Registration Parameters
Rigid
Deformable
Image Pyramid
Gaussian Pyramid
Gaussian Pyramid
Sampler
Random
Random Coordinate
Interpolator
B-Spline
B-Spline
Adaptive Stochastic Gradient
Adaptive Stochastic Gradient
Optimizer
Descent
Descent
Transform
Euler Transform
B-Spline
Normalized Correlation
Similarity Metric
Mutual Information
Coefficient
Regularization Term
Bending Energy Penalty
Following a successful registration, a MATLAB script converted the dCT from the mhd
image format used by elastix to DICOM for importing back to the treatment planning system
(TPS).

3.3 Validation of the DIR Method
Several methods were considered for validating the DIR method. Target registration
error (TRE), which uses pre-defined point pairs on registered images to measure the distance
between paired points after registration, is the gold standard for assessment of DIR. However,
this process is time consuming and labor-intensive, requiring an expert to spend hours
designating points which cover the entire registration volume. The next best option, which is
widely used to assess DIR accuracy, is a quantitative comparison between contours drawn on
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the fixed image and the deformed moving contours. Metrics were selected based on a
literature search to determine commonly used statistics, and Dice similarity coefficient (DSC),
Jaccard index (JI), and Hausdorff distance (HD) were chosen for validation 66,67,69,73–76.
The most frequently used contour analysis statistic, DSC calculates the spatial overlap
between two segmentations; if A is a contour drawn on CBCT and B is the corresponding
deformed contour, then

𝐷𝑆𝐶 =

2(𝐴 ⋂ 𝐵)
𝐴+𝐵
(3.1)

where ∩ is the intersection. Perfect overlap results in a DSC of 1, and no overlap at all
results in a DSC of 0. TG-132, a guidance document for the use of image registration in
radiotherapy, detailed the current approaches to registration and recommended guidelines for
quality assurance, including recommended DSC scores77. While TG-132 sets a goal of achieving
DSC of 0.8-0.9 for validating image registration methods, this is not always achievable for every
anatomical structure. Commercial algorithms have been found to fall short, specifically in HN,
with an average DSC of 0.73 for HN OARs in one study directly assessing TG-132
recommendations74.
JI is a stricter measure of the spatial overlap of two segmentations, calculated by

𝐽𝐼 =

|𝐴 ⋂ 𝐵|
|𝐴 ⋃ 𝐵 |
(3.2)

where ꓴ is the union of A and B. JI also ranges from 0 to 1, and while DSC and JI are equivalent
at 0 and 1, JI is always less than DSC between the two extremes.
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HD calculates the greatest distance between a point in one set and the closest point in a
second set. Given point a within A, the single-sided HD (HDS) is calculated as follows:
𝐻𝐷𝑆𝑚𝑎𝑥 (𝐴, 𝐵) = 𝑚𝑎𝑥𝑎 ∈𝐴 {𝑑𝑚𝑖𝑛 (𝑎, 𝐵)}
(3.3)

where dmin(a, B) indicates the minimal distance between point a and any point in B. This can
then be implemented to calculate symmetric HD as follows:
𝐻𝐷𝑚𝑎𝑥 (𝐴, 𝐵) = max {𝐻𝐷𝑆𝑚𝑎𝑥 (𝐴, 𝐵), 𝐻𝐷𝑆𝑚𝑎𝑥 (𝐵, 𝐴)}
(3.4)

A higher HD indicates dissimilarity between the two sets of points, while an HD of zero indicates
that A and B are identical sets of points. Voxels within the contour take the place of points for
HD when assessing segmentations.
Under the guidance of an expert physician, the mandible, cord, and parotids were
selected for evaluation structures, due to their importance in treatment planning and outcomes
for the patients of this work. Ten new HN cases were retrospectively chosen for validation
(Table 3.3). Patient selection was again limited to patients treated on the TrueBeam, and
patients with visible anatomic change were preferred. Structures were delineated by an expert
physician on CBCT, and the corresponding pCT contours were deformed according to the
transform parameters for the respective dCTs. MATLAB scripts then calculated DSC, JI, and HD
for each pair of structures.
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Pt #
1
2
3
4
5
6
7
8
9
10

Sex
M
F
M
M
M
M
M
F
M
F

Table 3.3 Patient Demographics for DIR Validation
Age
Disease Site
Stage
55 Oral cavity
T4aN3b
19 Nasopharynx
T2N1
49 Neck
T0N2aM0
68 Oropharynx
T4aN0
66 Larynx
T3N0M0 (III)
64 Larynx
T3N2cM0 (IVA)
57 Larynx
IVA
48 Nasal cavity
T4N0M0
49 Oropharynx
T2N2b
64 Oral cavity
T3N0

3.4 Results
3.4.1 DIR Validation
Registrations appeared reasonable upon visual inspection. Quantitative results based on
contours are summarized in Table 3.4. The mean DSC values were 0.78 and 0.71 for bony
anatomy and soft tissue, respectively. The mean JI values were 0.65 and 0.56, respectively. The
mean HD were 4.4mm and 3.6mm for bony anatomy and soft tissue, respectively.

Pt1
Pt2
Pt3
Pt4
Pt5
Pt6
Pt7
Pt8
Pt9
Pt10
Mean
Stdev
Min
Max

Table 3.4 Contour Evaluation Scores for Validation Patients
Mandible
Cord
Left Parotid
Right Parotid
DSC
JI
HD
DSC
JI
HD
DSC
JI
HD
DSC
JI
HD
0.70 0.55 5.1 0.83 0.71 2.4 0.71 0.56 4.1
N/A N/A N/A
0.85 0.73 5.8 0.71 0.55 3.9 0.62 0.45 3.1 0.50 0.33 3.3
0.82 0.69 7.5 0.69 0.53 2.9 0.78 0.64 3.3 0.81 0.67 3.5
0.78 0.65 4.9 0.75 0.59 2.4 0.67 0.50 3.5 0.39 0.24 4.1
0.87 0.77 6.1 0.74 0.59 2.6 0.77 0.63 3.1 0.82 0.69 3.7
0.88 0.78 4.4 0.73 0.57 4.6 0.75 0.60 3.9 0.77 0.63 3.5
0.90 0.82 4.1 0.71 0.56 2.6 0.79 0.66 2.6 0.80 0.66 3.7
0.86 0.76 6.1 0.77 0.62 3.1 0.83 0.72 3.7 0.78 0.64 3.7
0.80 0.67 7.3 0.67 0.51 2.9 0.68 0.51 3.5 0.72 0.56 4.3
0.75 0.61 6.9 0.81 0.68 2.6 0.55 0.38 3.1 0.65 0.48 4.1
0.82 0.70 5.8 0.74 0.59 3.0 0.72 0.56 3.4 0.69 0.55 3.8
0.06 0.08 1.1 0.05 0.06 0.7 0.08 0.10 0.4 0.14 0.15 0.3
0.71 0.55 4.1 0.67 0.51 2.4 0.55 0.38 2.6 0.39 0.24 3.3
0.90 0.82 7.5 0.83 0.82 4.6 0.83 0.72 4.1 0.82 0.69 4.3
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The DSC and JI values for the mandible significantly outperformed that for the cord.
Notably, the right parotid of Pt 4 had remarkably low DSC and JI values. This likely stems from
the difficulty of contouring soft tissue on CBCT, as the other structures for Pt 4 perform
reasonably well, and the artifacts and registration of the images do not differ significantly from
the other validation patients. Fig 3.3A shows the difference between the original contours and
the CBCT contours for Pt 4, which may explain the poor contour-based metrics. The SI extent of
the right parotid structure in particular was much smaller in the CBCT than in the pCT. On the
other hand, for Pt 7, the CBCT contours look much more similar to the original contours drawn
on the pCT (Fig. 3.3B). This points to interobserver variability strongly affecting contour
evaluation.

Fig. 3.3 A: Patient 4. B: Patient 7. 1: pCT with original contours. 2: CBCT with expert-drawn
contours for comparison to deformed contours. 3: dCT with deformed contours.
Mandible in lime, parotids in blue, and cord in green.
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As previously stated, inaccurate HU values from CBCT images is a primary barrier to
direct dose calculation. Therefore, HU values of the dCT were also evaluated. Histograms of the
HU values for the whole body structure as well as all four evaluation structures were generated
for the pCT, CBCT, and dCT (Fig. 3.4-5). Bin size was set to 10, and the histograms were overlaid
for analysis. The desired outcome was for the pCT and dCT histograms to demonstrate
reasonable agreement. This was generally achieved for all ten patients and all structures, apart
from the mandible exhibiting a larger peak towards the lower end of the histogram. Visual
inspection of the mandible contour revealed that the deformed structure included soft tissue
outside of the mandible, which is likely what causes this peak (Fig. 3.6). The original pCT
mandible contour included a small margin of soft tissue, and it expanded during deformation.
The CBCT contour, however, stayed within the bone, another difference between observers.

Fig 3.4 Histogram of HU values for the body structure for Pt 10. Bin size is 10 HU.
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Fig 3.5 Histogram of HU values for (A) mandible, (B) spinal cord, (C) left parotid, and (D) right
parotid for Pt 10. Bin size is 10 HU.

Fig 3.6 A: pCT, B: CBCT, C: dCT, with respective mandible contours in orange.
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3.4.2 Dose Calculation on dCTs
Following validation of the DIR method, the resulting dCTs were used for dose
calculation. The original treatment plan was transferred to the dCT and recalculated in Eclipse.
For the ten patients used for DIR validation, the pCT dose was compared to the dCT dose in
terms of typical OAR constraints and OAR DVHs.
The parotid gland dose was inconsistent across the ten patients, but the spinal cord and
mandible dose were likely to be higher on the dCT than the pCT (Fig. 3.7). For patients with
minimal anatomic change, DVHs for OARs appeared similar between the pCT and dCT (Fig. 3.8).
However, patients with larger anatomic change displayed a marked difference in their DVHs
(Fig. 3.9).
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Fig. 3.7 OAR doses on pCT and dCT for each of 10 HN patients. A, B: Parotid gland dose;
planning constraint of Dmean < 26 Gy indicated by the green line. C: Cord dose; planning
constraint of Dmax < 45 Gy (< 40 Gy if achievable) D: Mandible dose; planning constraint of
Dmax < 70 Gy.
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Fig. 3.8 DVH for a patient with little anatomic change. Solid lines are pCT, dashed is dCT.

Fig. 3.9 DVH for a patient with significant anatomic change. Solid lines are pCT, dashed is
dCT.
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Additionally, Dmax was calculated for the pCT and three dCTs from three time points
during the treatment course for a larger cohort of 47 patients. A slight trend of increase in D max
as treatment progressed was observed (Fig. 3.10).

Fig. 3.10 Dmax relative to the prescription dose for a cohort of 47 patients, showing a slight
increase over the treatment course.

3.5 Discussion
The developed method for deformable registration of CT to CBCT solved several
common issues encountered for this task, including limited FOV and inaccurate Hounsfield Unit
values for dose calculation. The method was developed using fifteen HN patients who exhibited
anatomic changes visible on CBCT and involved expanding the CBCT array to allow the resulting
dCT to have a larger FOV. The registration method was validated using ten additional HN
patients by assessing the DSC, JI, and HD between contours drawn on the CBCT and those
deformed from the pCT.
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The results for all contours are comparable to previous publications. Zukauskaite et al
evaluated DIR performance for registration of planning CT and recurrence CT images for HN
patients78. Their open-source algorithm achieved DSCs of 0.83, 0.79, 0.74, and 0.72 for the
mandible, spinal cord, and left and right parotid, respectively. Their study involved CT-CT
registration, as opposed to CT-CBCT registration, and a single observer contouring both image
sets. This may explain why their spinal cord value differs somewhat from ours, as they had no
interobserver variation and a larger extent of spinal cord included in their images. CT-CBCT DIR
was performed by Veiga for the purpose of dose of the day calculation 69. Using an open-source
algorithm, they achieved a DSC of 0.85 for bony anatomy and 0.79 for soft tissue, where bony
anatomy included the C1, C4, and C7 vertebrae and soft tissue included the external body
contour and the left and right sternocleidomastoid muscles. The use of vertebrae for contour
comparison, though not a typical OAR structure, avoids the innate ambiguity of delineating the
spinal cord. Additionally, the soft tissue structures used in their study are more easily visualized
on CBCT than parotids, as well as being larger in volume, which makes higher DSCs more easily
achievable. Jiang et al performed a HN CT-to-CBCT study to compare two DIR methods which
achieved HD ranging from 2.00 to 5.19 mm over soft tissue and bony anatomy using an opensource algorithm66.
A study investigating interobserver variability on HN CT found average DSC values of
0.90, 0.78, 0.82, and 0.83 for mandible, spinal cord, and left and right parotid, respectively, with
a large majority of the observers following the same guidelines for all contours apart from the
spinal cord. This indicates that our results are comparable to those of previous publications,
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despite limitations of our study, including interobserver variability and difficulty delineating soft
tissue structures on CBCT.
During validation, a limitation of our algorithm was identified, as the algorithm was
unable to generate acceptable registrations when presented with extreme image artifacts
caused by high density implants. Seven of the original ten patients selected had dental
implants, resulting in streaking and shadow artifacts on both the pCT and CBCT (Fig. 3.11). For
four of those patients, the artifacts severely affected the deformable registration, with
significant expansion of high intensity regions around the artifact. An attempt to mask out the
artifact so the registration would ignore it was unsuccessful (Fig. 3.11). This may be due to the
nature of the registration algorithm. The mask is applied to the reference image, but during
transformation, data from within the related area on the secondary image (pCT) will still be
visible and usable by the algorithm, and the pCT also exhibits artifacts. It may be possible to
improve this issue using a metal artifact reduction reconstruction algorithm on the pCT in
conjunction with masking out the CBCT artifact during registration. Since those four
registrations were unsuccessful, four additional patients without artifacts were selected to
replace them for the quantitative validation.
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Fig. 3.11 A patient whose artifact caused severe deformation errors. A: pCT, B: CBCT, C: dCT,
D: dCT with mask used to ignore artifact region.

A more minor CBCT artifact which affected the dCT quality was also detected. One
patient’s CBCT exhibited significant shadows at the posterior and inferior extreme of the scan,
which resulted in an indentation at that point in the back on the dCT (Fig. 3.12). The registration
mask could be altered for similar cases to not include the shadowed area. However, that
indentation is not expected to be significant enough to affect dose calculation negatively.
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Fig. 3.12 A patient with shadowing at the inferior edge of the CBCT (A), causing an indent in
the corresponding location in the dCT (B).
Due to the sensitivity of the registration method to artifacts, it did not perform as well
on an older OBI system with inherently poorer imaging quality. However, further work could
focus on making the method more robust to artifacts by testing different reconstruction
algorithms and masking methods.

3.6 Conclusion
A CT-CBCT DIR method was developed for the purpose of performing dose of the day
calculations. Using elastix, an open-source software package for image registration, the method
was able to generate dCTs reflecting the anatomy of the CBCT, with the HU and FOV of the pCT.
The method was validated on 10 HN patients, selected for anatomical change visible on CBCT,
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using contour evaluation methods. The developed DIR method was found to be reasonably
accurate for both bony anatomy and soft tissue. Since the external and bony anatomy are wellmatched in the dCT, it may be used for dose calculation, which is not very sensitive to small
differences in tissue density.
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Chapter 4 Development of Neural Network
This chapter summarizes the work performed to achieve specific aim 2 as outlined in
Chapter 1.5.

4.1 Machine Learning and Neural Networks
The field of machine learning is concerned with developing computational programs
which can “learn” in a similar way to humans, through exposure to repeated examples, in order
to improve performance in a specified task. This is in contrast to “hard-coding” programs to
perform a specific task. For example, a classification program could either be implemented by
making a database filled with examples of an object, or by feeding a machine learning algorithm
labeled examples, through which it can determine the hallmarks of the object itself. A benefit of
machine learning is that a computer program may find important attributes through this
process that the average human observer may miss.
There are many different approaches to machine learning, including but not limited to
linear regression, decision trees, and deep learning. Deep learning algorithms, or deep neural
networks (DNN), are comprised of several layers of artificial neurons79. These artificial neurons
are meant to emulate human neurons. Input data passes through weighted nodes, and the
outputs of the nodes are then summed and passed through an activation function to generate
the outputs of the layer. One layer feeds into another layer, and so on, until the output layer is
reached. Layers between the input layer and the output layer are referred to as hidden layers,
as they are unseen by the user, and DNNs can have many hidden layers. These layers perform
feature extraction and transformation, abstracting the data in ways that humans cannot, to find
patterns and structure.
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The training of a neural network may be supervised, unsupervised, or semi-supervised.
In supervised learning, the input data has labels or targets, and the network will compare its
prediction to the provided label. This comparison is performed via calculation of a loss function,
the exact form chosen based on the type of task being performed. The result of the loss
function is then propagated backwards through the network to update the weights of each
node, using a backpropagation gradient algorithm. The most popular algorithm for this purpose
is stochastic gradient descent. In unsupervised learning, there are no labels; the algorithm
clusters data and discovers patterns on its own. Semi-supervised learning falls between the
two. For the task of dose prediction outlined in this work, supervised learning was chosen, since
there was a known target to predict.
4.1.1 Convolutional Neural Networks
One of the most popular types of deep learning algorithms in radiotherapy specifically is
convolutional neural networks (CNN). CNNs have found great popularity in image analysis tasks,
as their architecture takes advantage of the spatial structure of image data, particularly in
medical images80. Rather than having each node in one layer connected to every single node of
the next layer, as in a standard DNN, which is computationally expensive, CNNs employ
convolutional blocks to process the data, which preserves the spatial nature of the data.
Convolutional filters (also known as kernels) take the place of the nodes, where the values of
the filter are the weights, and the pixel values of the image take the place of the input data. A
simplified example of an image being processed by a convolutional filter is presented in Fig. 4.1.
In this case, the image is a 5x5 array of values which can take either -1, 0, or 1. The filter’s
values have been arbitrarily assigned. The filter starts in the upper left corner of the image.
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Each (x,y) pixel value is multiplied by the corresponding (x,y) pixel value in the filter, and the
results are summed and then divided by the number of contributing pixels (in this case, 9). The
output of this operation is entered into pixel (2,2) of the output array, referred to as a feature
map. The filter then slides one column to the right, which is referred to as stride. Stride can take
any value and indicates the number of columns or rows the filter shifts over between
operations. Once the filter reaches the last column of the array, it moves one row down (for
stride=1) and continues on the next row. A convolutional neural network consists of many
convolutional filters with many weights, which are updated through backpropagation during
training.

Fig. 4.1 Convolution operation on an image.
A challenge when using convolutional layers is the size of feature maps produced by the
convolutional layers, which can often be quite large and computationally expensive to carry
through the whole network. To reduce this load, CNNs often feature pooling layers between
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convolutional layers. Max pooling is a common approach: a filter (different from the
convolutional filter) sweeps across the image in a similar fashion and, for each operation, keeps
only the maximum pixel value (Fig. 4.2). Depending on the size of the filter and the stride
chosen, this can greatly reduce the size of the feature map passed to the next layer.

Fig. 4.2 Max pooling operation on an image.
4.1.2 U-Net
A popular version of CNN architecture is the U-Net, originally developed by Ronneberger
et. al in 2015 for segmentation tasks81. The U-Net gets its name from the trademark shape of
the network architecture when illustrated, achieved by using a series of convolutional, pooling,
and rectified linear unit (ReLU) layers followed by a series of deconvolutional layers (Fig. 4.3).
ReLU is the standard activation function for many neural networks, including CNNs, and the
output of the ReLU is the same as the input unless the input is negative, in which case the
output is zero. Deconvolutional layers are transposed convolutional layers which upsample the
image. The first half of the U is a contracting path, while the second half of the U is an
expanding path bringing the image back to the original resolution. The initial contracting path
decreases the resolution of the image while increasing extracted features, and the subsequent
expanding path increases the resolution of the image while factoring in high-resolution features
from the contracting path. Skipped connections, illustrated in Fig. 4.3 as “copy and crop”
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arrows, allow for the propagation of features from earlier in the network to later layers,
skipping layers along the way. This architecture allows the network to learn from global and
local features of image sets, and it has been shown to work well with smaller image sets. It has
since been used for dose prediction as well as image segmentation in the radiotherapy field,
with many variations of it published in the literature82–84. One such variation added several
convolutional layers to the end of the U-Net to achieve better precision in prediction of threedimensional dose maps82. Another variation by the same group combined characteristics of
DenseNet, a network architecture valued for its efficiency in feature propagation and reusing
parameters by connecting all layers directly to each other, with U-Net to create a more efficient
network that would still be effective at capturing both local and global features 83. Kearney et al
used residual blocks to propagate information from earlier in the network to deeper portions of
the network84. Each variation outperformed the original architectures in accuracy of the
predicted dose maps and proved to be a potential tool for predicting 3D dose using just patient
contours. Due to a limited dataset and the goal of predicting 3D dose distributions, the U-Net
was chosen for this project.
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Fig. 4.3 The original U-Net architecture, with blue boxes corresponding to multi-channel
feature maps and arrows denoting the operations performed at each step 81.

4.2 Development of Neural Network
4.2.1 Patient Data
Patients were retrospectively selected for this study from those treated for HNC on
Varian TrueBeam linacs (Varian Medical Systems, Palo Alto, CA). The goal was to recruit 50
patients, and 47 patients were ultimately chosen over a three year period (Table 4.1). Patients
with noticeable anatomic change by the end of treatment were sought out, but many of the
included patients exhibited little change. Patients with severe high density artifacts which
affected deformation quality were excluded. Patient selection was not limited to a specific
disease origin; the majority of patients were oropharynx (OPX) cases. For those patients whose
weights were recorded (40), there was an average of 16 pounds (8.5%) lost over the course of
treatment.
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Table 4.1 Patient Demographics for Neural Network Development
Sex
Female
6
Male
41
Median age
59 (range 19-86)
Median weight before treatment (lbs)
177 (range 113-295)
Median weight after treatment (lbs)
163 (range 104-265)
Disease site
Oropharynx
20
Larynx
11
Nasal cavity
3
Nasopharynx
2
Oral cavity
5
Hypopharynx
1
Other
5
For each patient, one planning CT (pCT) and 3 cone-beam CTs (CBCT) were selected.
CBCTs were selected as close to the tenth, twentieth, and thirtieth fraction as possible to have
them evenly spread over the 30-33 fraction treatment course (Table 4.2). Deformed CTs (dCT)
were generated for each pCT-CBCT pair according to the method outlined in Chapter 3.

First CBCT
Second CBCT
Third CBCT

Table 4.2 Fraction numbers for each CBCT
Median fraction number
11 (range 7-16)
21 (range 16-23)
30 (range 24-33)

The dCTs were transferred back to the original TPS (Eclipse, Varian Medical Systems,
Palo Alto, CA) and registered with the pCT (Fig. 4.4). The original plan was then copied onto
each of the dCTs and the dose recalculated (Fig.4.5), using the Acuros calculation model with a
calculation resolution of 2.5 mm and the heterogeneity correction enabled. Dose maps were
exported in DICOM file type. The body contour for each pCT and dCT was refined and the
posterior half of the structure was removed to mimic what the AlignRT surface imaging system
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would see on the treatment table (Fig. 4.6). This “surface” structure was exported to the
AlignRT system to generate the AlignRT surface file, which uses a 3D obj file type. The surface is
composed of many triangles, and the obj file type stores this information through the
coordinates of the vertices and faces of the triangles.

Fig. 4.4 Flowchart depicting pre-processing steps for dose and surface data generation.

Fig. 4.5 Original treatment plan calculated on the pCT and the first, second, and third dCT.
PTV is contoured in red on the pCT.
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Fig. 4.6 Surface structure for an example patient. A: dCT with body contour in tan and
surface contour in green. B: AlignRT visualization of the same surface structure.
To generate image sets for the network, the exported surfaces and dose maps needed
to be converted to the same file type, in simple three-dimensional array format. The dCT
surface-dose map pairs also needed to be shifted to align with the original pCT surface-dose
map pair. A python script was written which converted the list of vertex coordinates in the
surface files to a three-dimensional binary array representing the surface, then shifted all arrays
so they were aligned with the original pCT. All arrays were also resampled to 3 mm/pixel
isotropically; the surfaces had varying resolutions but were generally 1 mm/pixel in all
directions. Dose maps were generally 1.17 x 1.17 x 3 mm3. Arrays were then cropped to
64x64x64 pixels to reduce computational expense while running the network. Since the field of
view for each patient’s scan was not consistent both in terms of size and relative position of
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patient anatomy, the crop window was manually chosen on the pCT dose map to extend
approximately from the bottom of the neck to the tip of the nose in the superior-inferior
direction and from the front of the face to the back of the head in the anterior-posterior
direction. The crop extent in the lateral direction was centered on the array as the images were
found to be centered laterally within the array. It was not always possible to include the entire
anterior-posterior extent of the head in the crop window; in this case, the inclusion of the face
was favored over the back of the head, as cheeks are known to exhibit some anatomic change
(Fig. 4.7).

Fig. 4.7 Example of cropping of dose array. A: Original dose distribution. B: Resampled and
cropped dose array. C: Surface overlay on dose array.
4.2.2 Network Architecture
The input to the network was a stack of volumes including the original pCT dose
distribution, the original pCT surface, and the “surface of the day”, the surface from a given
dCT. The target was the “dose of the day”, the dose from that same dCT calculated within the
treatment planning system. Since each of the 47 patients in the study had 3 dCTs, this resulted
in 141 input-target image sets. The original U-Net architecture was modified for threedimensional image sets and the size and shape of the input and target in this study. While
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training the network, the bottleneck at the base of the U was also extended by two
convolutional layers to improve performance (Fig. 4.8). The final convolutional layer originally
used a 3x3x3 filter but was updated to a 1x1x1 filter after referencing the original U-Net and
observing a slight improvement in performance with the 1x1x1 filter. The network was
implemented using Keras, a high-level API for machine learning implementation, in Google
Colab, a cloud-based Jupyter notebook with options for graphics processing unit (GPU) and
tensor processing unit (TPU) allocation for faster computing. TPUs are hardware specifically
developed for ML workload acceleration.

Fig. 4.8 U-Net architecture used for this study, with sizes for various layers and arrows
indicating different types of operations.
The loss function for training was mean squared error (MSE) between the predicted and
target dose distribution,
𝑛

1
𝑀𝑆𝐸 = ∑(𝑦𝑖 − 𝑦 ′ 𝑖 )2
𝑛
𝑖=1

(4.1)
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which is the sum of squared differences between each pixel value in the target and the
corresponding pixel value in the predicted dose distributions. This was chosen since the dose
prediction task is a regression problem and after studying other dose prediction neural
networks83–87. Root mean squared error (RMSE) and mean absolute error (MAE) were also used
as metrics to evaluate model performance during and after training:
𝑅𝑀𝑆𝐸 = √𝑀𝑆𝐸
𝑛

𝑀𝐴𝐸 =

(4.2)

1
∑ |𝑦𝑖 − 𝑦 ′ 𝑖 |2
𝑛
𝑖=1

(4.3)

RMSE and MAE are useful metrics since they give error in the same units as the variable of
interest, in this case dose. Both RMSE and MSE are more strongly affected by large outliers than
MAE, so one poorly performing prediction out of many well-performing predictions is likely to
result in a high MSE and RMSE but a lower MAE. Training with MAE as the loss metric was
performed, and while it resulted in lower MAE for training and validation sets, the MSE and
RMSE were higher. Given that the loss function is calculated over the whole array, including a
large volume of air, where errors are frequently small, MSE and RMSE were favored over MAE,
since MSE and RMSE would be less forgiving to larger deviations. Therefore, MSE was ultimately
kept as the loss function for training.
The Adaptive Moment Estimation (Adam) gradient descent algorithm was selected as
the optimizer after consulting literature84,86–89. Rather than having just one learning rate for
updating all weights, Adam assigns independent learning rates to each network weight, which is
beneficial for data where some features occur with very different frequencies than others and
is preferred for computer vision problems. The default values for the parameters of Adam were
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found to be suitable after training with other values and finding poor performance and a lack of
convergence.
Typically, neural networks include normalization to ensure all input data is on the same
scale and is therefore equally weighted. However, normalization becomes difficult when using
dose maps as both an input and the prediction target. Initially, dose distributions were input to
the network “as is”, in units of Gray (Gy). However, after seeing suboptimal performance, and
RMSE and MAE for both validation and training sets on the order of tens of Gy, the magnitude
of the input and target dose distributions was reduced. It was theorized that the network was
not taking into account the surface information, which was presented in 0s and 1s, since dose
values ranged between 0 and 70 Gy or more. The network was trained with the dose maps
divided by 10 and by 100, and the largest improvement was seen with dose divided by 100 (Fig.
4.9). This fits with expectation, as the dose divided by 100 was on the same scale as the surface
data, with all values falling between 0 and 1. Further reducing the magnitude of the dose did
not improve performance.
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Fig. 4.9 Loss plots for training data with (A) no division of dose arrays, (B) division by 10, and
(C) division by 100.
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4.2.3 Network Training
Six datasets were set aside for testing, from six different patients. Each of these datasets
included the pCT dose distribution, the pCT surface, the third dCT surface, and the third dCT
dose distribution. Since the other datasets from these patients included additional input
information and a different target, it was determined that it was permissible to have the other
datasets from those patients in the training or validation sets. The six test patients were
randomly selected from the ten patients used for DIR validation, with the goal of using the
contours from those patients for network evaluation. This left 135 image sets for training. In
the initial training and development phase, 119 sets were allotted to training and 16 to
validation to ensure no overfitting. This is approximately a 90/10 split between training and
validation and was manually executed by use of a random number generator. While 60/40 and
80/20 splits are often seen in machine learning development, a 90/10 split was preferred for
this project, given the small number of datasets. Image sets were randomly placed into either
training or validation, and the image sets were shuffled for training. After testing with various
batch sizes, a batch size of 7 was selected for the best performance. Fifty epochs were used for
training, but the model weights were saved when the validation loss was lowest, which may be
before reaching fifty epochs. It was found that training for more epochs resulted in overfitting
to the training data (Fig. 4.10).
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Fig. 4.10 Loss plot for 200 epochs using training data with dose values divided by 100.
K-fold cross-validation was also employed to assess the model, given the small number
of samples. This is done by splitting the dataset k ways. For example, if there are 100 samples
and 5-fold cross-validation is used, there will be 5 splits, each with 80 samples in the training
set and 20 samples in the validation set. Each sample then gets a chance to be in the training
and the validation sets. The model is then trained on each of the 5 splits, with new weights for
each split. Performance metrics are then averaged over all the splits. Five and ten are common
values for k, due to the computational expense of doing many splits; ten has been found to
result in generally low bias and small variance in results. Nine was chosen for k for this dataset,
as it divided evenly into the 135 image sets, meaning each split would have 120 training
samples and 15 validation samples. A batch size of 5 was used for the cross-validation, and
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training ran for 50 epochs. The best weights for each split were saved and evaluated on the test
set as well.
After choosing the best model using k-fold cross-validation, the final model was trained
using all 135 image sets, with a batch size of 5 and 45 epochs. The weights which achieved the
lowest loss were saved to use for test set prediction. Training took 9 minutes on the standard
GPU runtime available with Colab. Prediction of the test set of 6 samples took 1 second.

4.3 Network Evaluation
The predicted dose maps were multiplied by 100 to return to units of Gy for evaluation.
The true and predicted max and mean doses were calculated, as well as the RMSE and MAE for
each pair. Additionally, dose volumes were generated. In the absence of target contours, these
dose volumes were generated for the entire body. The true and predicted V100, V95, V90, V70,
V50, V20, and V10 were created. For each of these dose volumes, the DSC between the true
and predicted was calculated as a way to evaluate the similarity of the dose distributions. Dose
volume histograms (DVHs) for dose volumes were also generated. The volumes of the true and
predicted V100 and V90 were also calculated.
Table 4.3 shows the RMSE, MAE, difference in Dmax as a percentage of prescription dose,
and difference in Dmean in Gy; a negative value indicates the prediction was lower than the true
value. Overall, the predictions were “colder” than the true dose distributions. Of note is the
large Dmax difference shown in Pt 1; the reason for this is unknown, although the true Dmax for Pt
1 was much higher than that of other patients.
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Pt 1
Pt 2
Pt 3
Pt 4
Pt 5
Pt 6

RMSE

MAE

Table 4.3 Network performance on test set
True Dmax (Gy) Pred Dmax (Gy) Dmax diff (%)

5.18
3.21
7.00
4.04
3.06
3.03

2.24
1.41
4.13
1.94
1.57
1.63

84.42
69.16
73.45
77.18
79.38
77.62

74.24
67.06
70.77
76.68
75.41
75.69

-14.6
-3.3
-4.1
-0.72
-5.7
-2.8

Dmean diff (Gy)
-2.95
-3.14
0.20
-0.89
-0.04
-1.15

When looking at the dose volumes, Pt. 3 predicts much larger dose volumes than the
true volume, whereas the other patients exhibit the opposite phenomenon (Table 4.4). Pt 3 is
also the only patient where the predicted Dmax did not fall within the true V100. The reason for
this is unclear; however, Pt 3 did have a large dental implant resulting in artifacts on his scans,
which may affect dose calculation and the behavior the model expected.
Table 4.4 Differences in true and predicted isodose volumes as a percentage of true volume
ΔV100(%)
ΔV90(%)
Pt 1
-31.23
-9.55
Pt 2
-65.44
-19.72
Pt 3
563.53
26.98
Pt 4
-24.10
-7.27
Pt 5
-34.32
-16.03
Pt 6
-45.57
-13.41
DSCs for isodose volumes were lowest at V100 and rapidly increased (Fig. 4.11). DVHs
for dose volumes looked similar overall, albeit shifted towards lower doses from the true DVHs,
as the predictions were colder overall (Fig. 4.12). Fig 4.13 shows the true and predicted dose
distributions for Pt 4, the absolute difference map in Gy, and the true and predicted V100 and
V90 overlaid on the true and predicted dose distributions, as an example of the average
patient’s predicted dose.
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Fig. 4.11 DSC for true versus predicted isodose volumes

Fig. 4.12 Dose-volume histogram for true and predicted isodose volumes for Pt. 4.
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100

Fig. 4.13 Example predictions for Pt. 4. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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4.4 Discussion
A proof-of-concept neural network was developed which takes original dose
distribution, original surface, and treatment surface as input and delivers the predicted
treatment dose distribution as output. The model predictions prove that a neural network can
predict 3D dose distributions based on inputs of two surfaces and one dose distribution, which
has not been previously reported in the literature. Additionally, the prediction is carried out
very quickly on a standard GPU runtime. The current predictions mimic real dose distributions
quite closely. Interestingly, the edges are sharp where the network has surface data indicating
the edges of the body; the posterior surface of the patient, where the network does not know
the edge of the body, is fuzzy in the predictions.
However, the accuracy of the model predictions is inconsistent and indicates need for
further improvement. It is of interest that the network generally predicts colder than the true
values; investigating the cause of this is a priority. This could indicate that the network is
starting with the original dose distribution and essentially weighting individual pixels to get to
the treatment day dose distribution, since the treatment day dose distributions are observed to
have higher max doses than the original. The network may not be altering the distribution
enough due to limitations of the training. Two avenues for improvement have been identified:
further patient accrual and a custom loss function. More data is needed to further train the
network, and a custom loss function may improve training. The current loss function calculates
over the entire volume, which includes a large volume of air, an area that is easy to predict and
not of concern and therefore drives the loss down artificially. Finding a way to calculate the loss
solely on the body, or part of the body, could more accurately represent model performance
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while training and result in better learning. This could potentially be done by writing a custom
MSE function with a threshold to ignore low dose pixels. Additionally, the model architecture
could be modified to add different types of layers or additional inputs. For instance, a principal
component analysis operation could be carried out on surface changes before input to the UNet, and features extracted from that could be added as inputs to the U-Net. Another common
method for improving dose prediction models which could be explored is adding beam
geometry as an input.
The poorest performing patients, Pt 1 and Pt 3, may be outliers for this dataset, which
may explain the poor prediction. Pt 1 had a prescription of 69.96 Gy, but the true max on the
deformed CT was 84.42 Gy, which is higher than most of the patients included in this study. Pt 3
had a major dental implant which may affect the behavior of dose accumulation (Fig. 4.14).
While other patients with implants were included in the study, none were to the extent of Pt 3.
After patient recruitment had been ongoing for some time, a decision to exclude patients with
artifacts from dental implants was made due to the unreliability of the DIR method in handling
artifacts. However, patients which already had produced good registrations even with artifacts
were kept for training. There may simply not be enough patients with dental implants in the
network for it to predict those patients accurately. These results may indicate that different
models need to be trained for different dose levels or patients with artifacts. Predictions may
also improve by training separate models for different disease sites. Stratifying the data this
way would require a larger amount of data in order to train effectively.
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Fig. 4.14 Pt 3 dCT displaying high density artifact from dental implant, along with the true
and predicted dose for the same region.
Dose prediction neural networks have largely been developed for the purpose of
automating treatment planning, rather than predicting changes to delivered dose. However,
the metrics used to compare predicted dose distributions or DVHs to ground truth in
automated planning studies are still relevant in this context. Dmax and Dmean are commonly
reported, as well as DVHs and standard dose metrics for PTVs and OARs. Additionally, studies
frequently report DSC between isodose volumes. Average errors in predicted Dmax have been
reported as high as 10%, though more commonly in the range of 1-2%83,86. Errors in Dmean are
commonly reported in the 1-5% range86,87. DSCs for isodose volumes are commonly reported to
be greater than 0.9, though they have been reported in the 0.8-0.9 range for dose thresholds
below 40% of the prescription dose. The range in error in Dmax for the small test set of this study
was 0.7-14%, with 5 of the 6 patients having errors in excess of 2%, and DSCs for V90 to V100
isodose ranges were commonly below 0.9. The networks reported for comparison here used a
larger number of patients for their training and validation, while this study was limited in the
number of patients it was able to acquire, which limits training performance. The results
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indicate that there is great need for improvement in this model, which may be achieved
through the methods described above.
For this study, retrospective data was utilized. A prospective use of the network would
involve exporting the treatment plan dose to a workstation with the pre-processing scripts and
network code after planning is complete; the body contour would be exported to AlignRT to
generate a reference surface, and a surface capture would be obtained after setting up the
patient but before placement of the thermoplastic mask at every fraction (Fig. 4.15). At regular
intervals in the treatment course, both the reference surface and that day’s capture would then
be exported from AlignRT and input to the pre-processing scripts alongside the treatment dose,
and the pre-processing would feed directly into the network without manual intervention. The
output would be a 3D dose distribution reflecting the treatment day delivered dose.

Fig. 4.15 Flowchart depicting ideal workflow for clinical use of dose prediction network.

4.5 Conclusion
This project was able to develop a neural network as proof-of-concept for predicting 3D
dose of the day using the original dose distribution, the original surface, and the surface of the
day as inputs. The model architecture was based on the original U-Net, with modifications for
this dataset. The network was trained on 135 image sets and tested on 6 new image sets. The
results presented here are promising indicators of the ability of this type of model to serve as a
tool for making adaptive therapy decisions. However, further work is needed to improve the
accuracy and consistency of the predictions for it to be clinically viable.
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Chapter 5 Summary and Conclusions
The final chapter of this thesis summarizes the work presented here and discusses limitations of
the work and possible improvements.

5.1 Summary
The work presented in this dissertation demonstrates the feasibility of using a neural
network to predict changes to delivered dose in HN cases using surface data. This research
sought to accomplish two specific aims, with the purpose of improving HN radiotherapy: the
development and evaluation of a DIR method for CT-to-CBCT registration which delivered
deformed CTs with the field of view of planning CTs and the development and initial evaluation
of a neural network to predict changes in HN dose distributions based on surface data.
Fulfillment of the first specific aim was completed by the development and validation of
the DIR method described in Chapter 3. Using a combination of MATLAB and elastix, an opensource software package for image registration, a process was designed to register HN planning
CTs to CBCTs. The method was specifically designed to result in dCTs with the FOV of pCTs for
the purpose of more accurate dose calculation. Once validation of the DIR method was
completed and the method was determined to be adequate for dose calculation, work on the
second specific aim began. With the ability to generate dCTs for dose of the day calculation,
patients were recruited for neural network training. Treatment plans were recalculated on dCTs
and surfaces were generated, resulting in the data needed to train the network. Once preprocessing was completed, the network was developed and trained. The network was tested on
a small set of new patients to evaluate accuracy and verify proof-of-concept. The results
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demonstrated that the concept was feasible, but that the network needed improvements and
more training data.

5.2 Limitations and Future Work
Several limitations of the work and methods described here were discovered. The major
limitation of this study is the limited patient cohort. This stems partially from a limitation of the
developed DIR method. While some high density artifacts did not affect the quality of
registrations, the frequency of poor registrations due to high density artifacts caused by dental
implants led to an exclusion of most patients with high density artifacts from the network
training. This also restricted patient recruitment to only those treated on Varian TrueBeams
(Varian Medical Systems, Palo Alto, CA), as the poorer image quality of the on-board imagers on
other systems increased the severity and frequency of artifacts. Additionally, patients who had
replans performed mid-course were excluded, as the aim was to collect CBCTs throughout the
entire treatment course that would be registered with the original pCT. In the future, these
patients could be used to validate the dose prediction with dose calculated on the repeat CT,
provided the setup is consistent. On the other hand, recruitment was largely limited to patients
who exhibited visible anatomic change on CBCT, as those would be most likely to exhibit
significant dosimetric change. Recruitment was eventually extended to patients with little to no
anatomic change due to the low patient numbers, but this composed only a small subset of the
patient cohort. Further training with a larger dataset is necessary to improve the network
performance and move towards viability for use as a clinical tool. A larger dataset would also
permit stratification based on dose metrics or site, which could further improve model
performance.
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There are several avenues to pursue for improving model performance. While a larger
dataset will likely have the most impact, pre-processing is also critical to training. The current
method for generating surface masks from the AlignRT files is known to have errors in certain
sections of the array, most notably the superior-inferior transition from shoulders to neck. The
method for drawing the polygons based on coordinates makes errors in determining where the
interior of the polygon should be. The errors are restricted to a small section of the array and
do not occur on all patients; however, the dose prediction is less accurate in that region due to
the inaccuracy of the array. A solution for this has not yet been found but is an active point of
focus. The network could be trained using the structure directly from the TPS, which would
eliminate this error. However, the intent is for the network and pre-processing steps to use
surfaces from AlignRT for prediction, since a surface structure would not be available in the TPS
for each new fraction, so a solution must be found eventually.
The neural network may additionally benefit from alterations to the architecture, which
may come in the form of additional convolutional layers, fully connected layers, residual blocks,
or others. Benefits of these adaptations to the architecture could be seen more clearly with a
larger dataset for training and a full set of patients for testing. One clear modification to the
network would be a custom loss function. The current loss function calculates on the entire
array, which includes a large volume of air, where small errors are frequent, and therefore the
loss is artificially low. A custom loss function which calculates only on the body may improve
learning drastically. This may require an additional input of the original body structure to the
network. Attempts to create a custom loss function thus far have been unsuccessful.
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Once the network is evaluated to be clinically viable, it will be necessary to determine
and implement useful metrics which could be reported to physicians for the purposes of
making clinical decisions about whether patients need resimulation and replanning. These
metrics would need to be independent of contours and could include reporting the change in
Dmax or isodose volumes. While contour-based metrics would be ideal, the process of obtaining
those metrics independent of DIR or CBCT is not trivial. The simplest method would be to
evaluate the dose distribution using the pCT contours; however, this ignores the effect of any
anatomic change on the structures themselves. To generate DVHs or new contours
independent of DIR or CBCT that accurately reflect the geometry of the contours at each
treatment fraction would likely require the development of an additional neural network
separate from the one presented here. After acceptable metrics are chosen, it would then be
ideal to perform a prospective study with the clinical tool implemented.

5.3 General conclusions
This thesis investigated the development of a CT-to-CBCT DIR method and a 3D dose
prediction neural network for HN patients treated with RT. This research was driven by two
specific aims.
The first, to develop a CT-to-CBCT DIR method, was necessary due to the lack of
commercially available DIR packages which preserve the field of view of the pCT when
generating the dCT. Without an image with a full field of view and correct HU, accurate dose
calculation is impossible. Therefore, an in-house method was developed which addressed these
challenges and was validated on ten patients. Validation demonstrated that the method was
comparable to published in-house and commercial algorithms. The increased FOV of the dCT
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relative to commercially-generated dCTs allowed for accurate dose-of-the-day calculation and
surface generation, necessary for the second aim.
The second aim included the development and evaluation of a proof-of-concept neural
network in the pursuit of creating a clinical tool for informing clinical decisions about replanning
during a HN patient’s treatment course. The developed neural network uses the original dose
distribution and surface information to predict how the dose distribution has changed. The
predictions for test patients indicate the need for improvement in accuracy, but they are
promising indicators of feasibility. Given a larger patient cohort and the modifications to the
pre-processing methods and network proposed above, it is expected that the model could be
developed into a useful clinical tool.
Both the first and second specific aims were successfully achieved, and a novel method
for predicting dose changes during HN RT was presented which shows promise for clinical use
and improving adaptive therapy.
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Appendix A Additional Figures
This appendix includes patient-specific figures for the DIR validation, dose calculation on the
DIR validation patients, and neural network test set.

A.1 HU Histograms

Fig A.1 Histograms of HU values for pCT, CBCT, and dCT for Pt. 1. A: Body, B: Left parotid, C:
Cord, D: Mandible. Note: Pt.1 did not have a right parotid.
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Fig A.2 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 2.

Fig A.3 Histograms of HU values for pCT, CBCT, and dCT for Pt. 2. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.4 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 3.

Fig A.5 Histograms of HU values for pCT, CBCT, and dCT for Pt. 3. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.6 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 4.

Fig A.7 Histograms of HU values for pCT, CBCT, and dCT for Pt. 4. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.8 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 5.

Fig A.9 Histograms of HU values for pCT, CBCT, and dCT for Pt. 5. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.10 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 6.

Fig A.11 Histograms of HU values for pCT, CBCT, and dCT for Pt. 6. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.12 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 7.

Fig A.13 Histograms of HU values for pCT, CBCT, and dCT for Pt. 7. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.14 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 8.

Fig A.15 Histograms of HU values for pCT, CBCT, and dCT for Pt. 8. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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Fig A.16 Histogram of HU values of the body for pCT, CBCT, and dCT for Pt. 9.

Fig A.17 Histograms of HU values for pCT, CBCT, and dCT for Pt. 9. A: Left parotid, B: Right
parotid, C: Cord, D: Mandible.
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A.2 OAR DVHs

Fig A.18 DVHs for selected OARs for Pt. 1 comparing dose on pCT (solid) to dose on dCT
(dashed). Note: Pt. 1 did not have a right parotid.

Fig A.19 DVHs for selected OARs for Pt. 3 comparing dose on pCT (solid) to dose on dCT
(dashed).
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Fig A.20 DVHs for selected OARs for Pt. 4 comparing dose on pCT (solid) to dose on dCT
(dashed).

Fig A.21 DVHs for selected OARs for Pt. 5 comparing dose on pCT (solid) to dose on dCT
(dashed).
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Fig A.22 DVHs for selected OARs for Pt. 6 comparing dose on pCT (solid) to dose on dCT
(dashed).

Fig A.23 DVHs for selected OARs for Pt. 7 comparing dose on pCT (solid) to dose on dCT
(dashed).
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Fig A.24 DVHs for selected OARs for Pt. 8 comparing dose on pCT (solid) to dose on dCT
(dashed).

Fig A.25 DVHs for selected OARs for Pt. 9 comparing dose on pCT (solid) to dose on dCT
(dashed).
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A.3 Neural Network Predictions

Fig. A.26 DVH for true and predicted isodose volumes for Pt. 1.
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Fig. A.27 Example predictions for Pt. 1. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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Fig. A.28 DVH for true and predicted isodose volumes for Pt. 2.
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Fig. A.29 Example predictions for Pt. 2. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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Fig. A.30 DVH for true and predicted isodose volumes for Pt. 3.
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Fig. A.31 Example predictions for Pt. 3. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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Fig. A.32 DVH for true and predicted isodose volumes for Pt. 5.
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Fig. A.33 Example predictions for Pt. 5. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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Fig. A.34 DVH for true and predicted isodose volumes for Pt. 6.
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Fig. A.35 Example predictions for Pt. 6. A: Corresponding dCT slice, B: predicted minus true
dose difference map (Gy), C: true and predicted V100 overlay, D: true and predicted V90
overlay.
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Appendix B Code
This appendix contains code written for this project.

B.1 Image registration parameter files
The following is the parameter file used for rigid registration:
// Example parameter file for rotation registration
// C-style comments: //
// The internal pixel type, used for internal computations
// Leave to float in general.
// NB: this is not the type of the input images! The pixel
// type of the input images is automatically read from the
// images themselves.
// This setting can be changed to "short" to save some memory
// in case of very large 3D images.
(FixedInternalImagePixelType "float")
(MovingInternalImagePixelType "float")
// Specify whether you want to take into account the so-called
// direction cosines of the images. Recommended: true.
// In some cases, the direction cosines of the image are corrupt,
// due to image format conversions for example. In that case, you
// may want to set this option to "false".
(UseDirectionCosines "true")
// **************** Main Components **************************
// The following components should usually be left as they are:
(Registration "MultiResolutionRegistration")
(Interpolator "BSplineInterpolator")
(ResampleInterpolator "FinalBSplineInterpolator")
(Resampler "DefaultResampler")
// These may be changed to Fixed/MovingSmoothingImagePyramid.
// See the manual.
(FixedImagePyramid "FixedRecursiveImagePyramid")
(MovingImagePyramid "MovingRecursiveImagePyramid")
// The following components are most important:
// The optimizer AdaptiveStochasticGradientDescent (ASGD) works
// quite ok in general. The Transform and Metric are important
// and need to be chosen careful for each application. See manual.
(Optimizer "AdaptiveStochasticGradientDescent")
(Transform "EulerTransform")
(Metric "AdvancedNormalizedCorrelation")
//(Metric "AdvancedMattesMutualInformation")
//***********Mask**********
(ErodeMask "true")
// ******Similarity Measure*********
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// Number of grey level bins in each resolution level,
// for the mutual information. 16 or 32 usually works fine.
// You could also employ a hierarchical strategy:
//(NumberOfHistogramBins 16 32 32 64)
(NumberOfHistogramBins 32)
// ***************** Transformation **************************
// Scales the rotations compared to the translations, to make
// sure they are in the same range. In general, it's best to
// use automatic scales estimation:
(AutomaticScalesEstimation "true")
// Automatically guess an initial translation by aligning the
// geometric centers of the fixed and moving.
(AutomaticTransformInitialization "true")
// Whether transforms are combined by composition or by addition.
// In generally, Compose is the best option in most cases.
// It does not influence the results very much.
(HowToCombineTransforms "Compose")
// ******************** Multiresolution **********************
// The number of resolutions. 1 Is only enough if the expected
// deformations are small. 3 or 4 mostly works fine. For large
// images and large deformations, 5 or 6 may even be useful.
(NumberOfResolutions 4)
// The downsampling/blurring factors for the image pyramids.
// By default, the images are downsampled by a factor of 2
// compared to the next resolution.
// So, in 2D, with 4 resolutions, the following schedule is used:
//(ImagePyramidSchedule 8 8 4 4 2 2 1 1 )
// And in 3D:
//(ImagePyramidSchedule 8 8 8 4 4 4 2 2 2 1 1 1 )
// You can specify any schedule, for example:
//(ImagePyramidSchedule 4 4 4 3 2 1 1 1 )
// Make sure that the number of elements equals the number
// of resolutions times the image dimension.
// ******************* Optimizer ****************************
// Maximum number of iterations in each resolution level:
// 200-500 works usually fine for rigid registration.
// For more robustness, you may increase this to 1000-2000.
(MaximumNumberOfIterations 300)
// The step size of the optimizer, in mm. By default the voxel size is
used.
// which usually works well. In case of unusual high-resolution images
// (eg histology) it is necessary to increase this value a bit, to the
size
// of the "smallest visible structure" in the image:
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//(MaximumStepLength 1.0)
// **************** Image sampling **********************
// Number of spatial samples used to compute the mutual
// information (and its derivative) in each iteration.
// With an AdaptiveStochasticGradientDescent optimizer,
// in combination with the two options below, around 2000
// samples may already suffice.
(NumberOfSpatialSamples 3000)
// Refresh these spatial samples in every iteration, and select
// them randomly. See the manual for information on other sampling
// strategies.
(NewSamplesEveryIteration "true")
(ImageSampler "RandomCoordinate")
// ************* Interpolation and Resampling ****************
// Order of B-Spline interpolation used during registration/optimisation.
// It may improve accuracy if you set this to 3. Never use 0.
// An order of 1 gives linear interpolation. This is in most
// applications a good choice.
(BSplineInterpolationOrder 1)
// Order of B-Spline interpolation used for applying the final
// deformation.
// 3 gives good accuracy; recommended in most cases.
// 1 gives worse accuracy (linear interpolation)
// 0 gives worst accuracy, but is appropriate for binary images
// (masks, segmentations); equivalent to nearest neighbor interpolation.
(FinalBSplineInterpolationOrder 3)
//Default pixel value for pixels that come from outside the picture:
(DefaultPixelValue -1000)
// Choose whether to generate the deformed moving image.
// You can save some time by setting this to false, if you are
// only interested in the final (nonrigidly) deformed moving image
// for example.
//(WriteResultImageAfterEachResolution "true")
(WriteResultImage "true")
//(ShowExactMetricValue "true")
// The pixel type and format of the resulting deformed moving image
(ResultImagePixelType "short")
(ResultImageFormat "mhd")
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The following is the parameter file used for deformable registration:
(FixedInternalImagePixelType "float")
(MovingInternalImagePixelType "float")
(FixedImageDimension 3)
(MovingImageDimension 3)
(UseDirectionCosines "true")
// **************** Main Components **************************
(Registration "MultiMetricMultiResolutionRegistration")
//(Registration "MultiResolutionRegistration")
(Interpolator "BSplineInterpolator")
(ResampleInterpolator "FinalBSplineInterpolator")
(Resampler "DefaultResampler")
//(FixedImagePyramid "FixedSmoothingImagePyramid")
//(MovingImagePyramid "MovingSmoothingImagePyramid")
(FixedImagePyramid "FixedRecursiveImagePyramid")
(MovingImagePyramid "MovingRecursiveImagePyramid")
(Optimizer "AdaptiveStochasticGradientDescent")
(Transform "BSplineTransform")
(Metric "AdvancedMattesMutualInformation" "TransformBendingEnergyPenalty")
//(Metric "AdvancedMattesMutualInformation")
(Metric0Weight 1)
(Metric1Weight 25) // OPTIMIZED BY QUANTITATIVE MEASURES
//********Mask*******
(ErodeMask "true")
// ***************** Transformation **************************
//(GridSpacingSchedule 4 2 1)
//(FinalGridSpacingInPhysicalUnits 15)
(HowToCombineTransforms "Compose")
// ******************* Similarity measure *********************
(NumberOfHistogramBins 32) // OPTIMIZED BY QUANTITATIVE MEASURES
// ******************** Multiresolution **********************
(NumberOfResolutions 3)
(ImagePyramidSchedule 8 8 2
RESOLUTION

4 4 1

1 1 1) // ACCOUNTING FOR ANISOTROPIC

// ******************* Optimizer ****************************
(MaximumNumberOfIterations 2500) // COULD PROBABLY BE LOWERED, ESPECIALLY FOR
THE FIRST LEVELS OF THE IMAGE PYRAMID
(ASGDParameterEstimationMethod "DisplacementDistribution")
// **************** Image sampling **********************
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(NumberOfSpatialSamples 3000) // COULD PROBABLY BE LOWERED, ESPECIALLY FOR
THE FIRST LEVELS OF THE IMAGE PYRAMID
(NewSamplesEveryIteration "true")
(ImageSampler "RandomCoordinate")
//(SampleRegionSize 40) // OPTIMIZED BY QUANTITATIVE MEASURES
//(UseRandomSampleRegion "true")
//(MaximumNumberOfSamplingAttempts 5)
//(RequiredRatioOfValidSamples 0.05)
// ************* Interpolation and Resampling ****************
(BSplineInterpolationOrder 1)
(FinalBSplineInterpolationOrder 3)
(ShowExactMetricValue "false")
(WriteTransformParametersEachResolution "true")
//(WriteResultImageAfterEachResolution "true")
//(WritePyramidImagesAfterEachResolution "true")
(DefaultPixelValue -1000)
(WriteResultImage "true")
(ResultImagePixelType "short")
(ResultImageFormat "mhd")

B.2 MATLAB Code
The following are scripts used for processing the images before and after image registration, as
well as the script for contour comparison.
B.2.1 Preparing for registration
This script creates the resampled and padded CBCT image and the mask based on the input
CBCT and pCT.
function[createImages] = createCBCTandMask(CBCTimage, Simimage, CBCTbkg, Maskbkg,
ResampledName, MaskName, PadName, MaskPadName)
RescaleMetaImage(CBCTimage, Simimage, ResampledName);
[CBimg, CBhdr] = OpenMetaImageSH(strcat(ResampledName, '.mhd'));
mask = CylinderMask(CBimg);
WriteMetaImageSH(MaskName, mask, CBhdr);
PadMetaImage(strcat(ResampledName, '.mhd'), Simimage, CBCTbkg, PadName);
PadMetaImage(strcat(MaskName, '.mhd'), Simimage, Maskbkg, MaskPadName);
end
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This script resamples the CBCT to the same resolution as the pCT.
function[resizedImg] = RescaleMetaImage(ImgPath, SimPath, ResizedImgName)
[CBimg, CBhdr] = OpenMetaImageSH(ImgPath);
[Simimg, Simhdr] = OpenMetaImageSH(SimPath);
newx = round(size(CBimg,1)*CBhdr.x_pixdim/Simhdr.x_pixdim);
newy = round(size(CBimg,2)*CBhdr.y_pixdim/Simhdr.y_pixdim);
newz = round(size(CBimg,3)*CBhdr.z_pixdim/Simhdr.z_pixdim);
resizedImg = imresize3(CBimg, [newx, newy, newz], 'linear');
CBhdr.x_pixdim = Simhdr.x_pixdim;
CBhdr.y_pixdim = Simhdr.y_pixdim;
CBhdr.z_pixdim = Simhdr.z_pixdim;
CBhdr.x_dim = newx;
CBhdr.y_dim = newy;
CBhdr.z_dim = newz;
WriteMetaImageSH( ResizedImgName, resizedImg, CBhdr);
end

This script pads the resampled CBCT to approximately the same array size as the pCT.
function[paddedImg] = PadMetaImage(ImgPath, SimPath, BackgroundNumber, PaddedImgName)
[CBimg, CBhdr] = OpenMetaImageSH(ImgPath);
[Simimg, Simhdr] = OpenMetaImageSH(SimPath);
paddedImg = BackgroundNumber*ones(size(Simimg));
CBx = size(CBimg, 1);
CBy = size(CBimg, 2);
CBz = size(CBimg, 3);
xdiff = size(Simimg,1) - size(CBimg,1);
ydiff = size(Simimg,2) - size(CBimg,2);
zdiff = size(Simimg,3) - size(CBimg,3);
if mod(xdiff, 2) == 1 %is odd
paddedImg = paddedImg(1:end-1,1:end-1,:);
xdiff = xdiff - 1;
ydiff = ydiff - 1; %should separate out y from x in case of non-square array
end
if mod(zdiff, 2) == 1 %is odd
paddedImg = paddedImg(:,:,1:end-1);
zdiff = zdiff - 1;
end
paddedImg(xdiff/2+1:(CBx+xdiff/2), ydiff/2+1:(CBy+ydiff/2), zdiff/2+1:(CBz+zdiff/2)) =
CBimg(:,:,:);
CBhdr.x_dim = size(paddedImg,1);
CBhdr.y_dim = size(paddedImg,2);
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CBhdr.z_dim = size(paddedImg,3);
WriteMetaImageSH( PaddedImgName, paddedImg, CBhdr);
end

This script creates the cylindrical mask for the FOV of the CBCT.
function[mask] = CylinderMask(img)
[x,y,z] =size(img);
mask = zeros(x,y,z);
for i = 4:(z-3); %shortened mask on 05/11/20 from 2:(z-1) to avoid truncation effects
imshow(img(:,:,i))
%
if i == 1 | i == z
%
r = (x-72)/2;
%
circ = drawcircle('Center',[x/2,y/2],'Radius',r);
%
else
circ = drawcircle('Center',[x/2,y/2],'Radius',x/2);
%
end
mask(:,:,i) = createMask(circ);
end
end

This script resamples the cylindrical mask to the resolution of the pCT.
function[resizedImg] = RescaleMetaImage(ImgPath, SimPath, ResizedImgName)
[CBimg, CBhdr] = OpenMetaImageSH(ImgPath);
[Simimg, Simhdr] = OpenMetaImageSH(SimPath);
newx = round(size(CBimg,1)*CBhdr.x_pixdim/Simhdr.x_pixdim);
newy = round(size(CBimg,2)*CBhdr.y_pixdim/Simhdr.y_pixdim);
newz = round(size(CBimg,3)*CBhdr.z_pixdim/Simhdr.z_pixdim);
resizedImg = imresize3(CBimg, [newx, newy, newz], 'nearest');
CBhdr.x_pixdim = Simhdr.x_pixdim;
CBhdr.y_pixdim = Simhdr.y_pixdim;
CBhdr.z_pixdim = Simhdr.z_pixdim;
CBhdr.x_dim = newx;
CBhdr.y_dim = newy;
CBhdr.z_dim = newz;
WriteMetaImageSH( ResizedImgName, resizedImg, CBhdr);
end
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B.2.2 Additional MATLAB Scripts
This script converts the dCT from mhd format to DICOM format for import to TPS, using info
from the pCT DICOM tags.
function[newDicom] = convertMHDtoDICOM(dCT, pCTdicom, CBCTdate, CBCTdateDec,
dicomFolder, dicomName)
%dCT 'filename.mhd'
%pCTdicom 'pathname/slicename.dcm'
%CBCTdate 'yyyymmdd'
%CBCTdateDec 'mm.dd.yyyy'
%dicomFolder - name of dicom folder to be created
%ex:'ANON11111_CBCT#_DICOM'
%dicomName - name of dicom slices ex:'ANON11111_mmddyyyy_CBCT_'
[dCTimg, dCThdr] = OpenMetaImageSH(dCT);
pCTinfo = dicominfo(pCTdicom);
studyuid = dicomuid;
seriesuid = dicomuid;
instanceuid = dicomuid;
refuid = dicomuid;
origPos = pCTinfo.ImagePositionPatient;
origSlice = origPos(3);
pCTinfo.FileModDate = string(datetime('now'));
pCTinfo.FileSize = '';
pCTinfo.Width = dCThdr.x_dim;
pCTinfo.Height = dCThdr.y_dim;
pCTinfo.MediaStorageSOPInstanceUID = instanceuid;
pCTinfo.ImplementationVersionName = '';
pCTinfo.SpecificCharacterSet = '';
pCTinfo.InstanceCreationDate = '';
pCTinfo.InstanceCreationTime = '';
pCTinfo.SOPInstanceUID = instanceuid;
pCTinfo.StudyDate = CBCTdate;
pCTinfo.SeriesDate = CBCTdate;
pCTinfo.AcquisitionDate = CBCTdate;
pCTinfo.ContentDate = CBCTdate;
pCTinfo.SeriesDescription = strcat('CT_HN.', CBCTdateDec);
pCTinfo.StudyInstanceUID = studyuid;
pCTinfo.SeriesInstanceUID = seriesuid;
pCTinfo.StudyID = strcat('DIR ', CBCTdate);
pCTinfo.SeriesNumber = [];
pCTinfo.FrameOfReferenceUID = refuid;
pCTinfo.Rows = dCThdr.x_dim;
pCTinfo.Columns = dCThdr.y_dim;
pCTinfo.RescaleIntercept = 0;
pCTinfo.RescaleSlope = 1;
mkdir(dicomFolder);
for i = 1:size(dCTimg, 3)
filename = strcat(dicomName, sprintf('%04d', i));
pCTinfo.Filename = filename;
pCTinfo.InstanceNumber = i;
pCTinfo.ImagePositionPatient = origPos - [0; 0; pCTinfo.SliceThickness*(i-1)];
pCTinfo.SliceLocation = origSlice - pCTinfo.SliceThickness*(i-1);
dicomwrite(dCTimg(:,:,i), strcat(dicomFolder, '\', filename, '.dcm'), pCTinfo);
end
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end

This script calculates DSC, JI, and HD between two contours.
function[compareContours] = contourCompare(BQContourPath, simPath,
resampleContourPath, padContourPath, defContourPath)
%Rescale and pad CBCT contour
RescaleMetaImage(BQContourPath, simPath, resampleContourPath);
PadMetaImage(strcat(resampleContourPath, '.mhd'), simPath, 0, padContourPath);
%Open both masks
maskBQ = OpenMetaImageSH(strcat(padContourPath, '.mhd'));
maskDef = OpenMetaImageSH(defContourPath);
%Binarize both masks
bmaskBQ = imbinarize(maskBQ);
bmaskDef = logical(maskDef);
%Find extent of CBCT mask
slices = size(bmaskBQ, 3);
ind_vector = zeros(slices);
for i = 1:slices
slice = bmaskBQ(:,:,i);
if max(slice(:)) == 1
ind_vector(i) = 1;
end
end
index1 = find(ind_vector, 1);
index2 = find(ind_vector, 1, 'last');
len = index2-index1 + 1;
dsc = dice(bmaskBQ(:,:,index1:index2), bmaskDef(:,:,index1:index2));
hdarray = zeros(1,len);
jac = jaccard(bmaskBQ(:,:,index1:index2), bmaskDef(:,:,index1:index2));
j = 1;
for i = index1:index2
[hd D] = HausdorffDist(bmaskBQ(:,:,i), bmaskDef(:,:,i));
hdarray(j) = hd;
j = j + 1;
end
hdavg = max(hdarray(:));
disp(['The DSC is ', num2str(dsc), '. The HD is ', num2str(hdavg), '. The Jaccard
Index is ', num2str(jac), '.'])
end
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B.3 Python Code
The following code includes programs to process data for input to the neural network, the
neural network itself, and scripts for analysis of predictions.
B.3.1 Pre-processing
The following code performs conversion of surface obj files and dose files, resamples all arrays
to isotropic resolution, and aligns and crops all arrays.
def convertSurfandDose(ptid, ptnum):
surf0Path = '/content/drive/MyDrive/Colab/HNSI/Source/SimSurface/' + pti
d + '/Sim/capture.obj'
surf1Path = '/content/drive/MyDrive/Colab/HNSI/Source/CBCTSurface/' + pt
id + '/CBCT1/capture.obj'
surf2Path = '/content/drive/MyDrive/Colab/HNSI/Source/CBCTSurface/' + pt
id + '/CBCT2/capture.obj'
surf3Path = '/content/drive/MyDrive/Colab/HNSI/Source/CBCTSurface/' + pt
id + '/CBCT3/capture.obj'
dose0Path = '/content/drive/MyDrive/Colab/HNSI/Source/SimDose/' + ptid +
'/Sim/RD.' + ptid + '.ANON.dcm'
dose1Path = '/content/drive/MyDrive/Colab/HNSI/Target/CBCTDose/' + ptid
+ '/CBCT1/RD.' + ptid + '.CBCT1.dcm'
dose2Path = '/content/drive/MyDrive/Colab/HNSI/Target/CBCTDose/' + ptid
+ '/CBCT2/RD.' + ptid + '.CBCT2.dcm'
dose3Path = '/content/drive/MyDrive/Colab/HNSI/Target/CBCTDose/' + ptid
+ '/CBCT3/RD.' + ptid + '.CBCT3.dcm'
surf0nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Surface/0/' +
ptnum + '.nrrd'
surf1nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Surface/1/' +
ptnum + '.nrrd'
surf2nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Surface/2/' +
ptnum + '.nrrd'
surf3nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Surface/3/' +
ptnum + '.nrrd'
dose0nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Dose/0/' + ptn
um + '.nrrd'
dose1nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Dose/1/' + ptn
um + '.nrrd'
dose2nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Dose/2/' + ptn
um + '.nrrd'
dose3nrrd = '/content/drive/MyDrive/Colab/HNSI/CenterCrop/Dose/3/' + ptn
um + '.nrrd'
#convert all the surfaces to xarrays
surf0 = convertOBJ(surf0Path)
surf1 = convertOBJ(surf1Path)
surf2 = convertOBJ(surf2Path)
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surf3 =
#import
xdose0,
xdose1,
xdose2,
xdose3,

convertOBJ(surf3Path)
dose distributions and obtain xarray,
d0, d0xcoords, d0ycoords, d0zcoords =
d1, d1xcoords, d1ycoords, d1zcoords =
d2, d2xcoords, d2ycoords, d2zcoords =
d3, d3xcoords, d3ycoords, d3zcoords =

numpy array, and coords
importDose(dose0Path)
importDose(dose1Path)
importDose(dose2Path)
importDose(dose3Path)

#separate numpy array from coords of surfaces
nsurf0, s0xcoords, s0ycoords, s0zcoords = xyz_and_numpy_from_xarray(surf
0)
nsurf1, s1xcoords, s1ycoords, s1zcoords = xyz_and_numpy_from_xarray(surf
1)
nsurf2, s2xcoords, s2ycoords, s2zcoords = xyz_and_numpy_from_xarray(surf
2)
nsurf3, s3xcoords, s3ycoords, s3zcoords = xyz_and_numpy_from_xarray(surf
3)
#get resolutions of surfaces and dose
s0xres, s0yres, s0zres = getxyzRes(s0xcoords,
s1xres, s1yres, s1zres = getxyzRes(s1xcoords,
s2xres, s2yres, s2zres = getxyzRes(s2xcoords,
s3xres, s3yres, s3zres = getxyzRes(s3xcoords,
d0xres, d0yres, d0zres = getxyzRes(d0xcoords,
d1xres, d1yres, d1zres = getxyzRes(d1xcoords,
d2xres, d2yres, d2zres = getxyzRes(d2xcoords,
d3xres, d3yres, d3zres = getxyzRes(d3xcoords,

s0ycoords,
s1ycoords,
s2ycoords,
s3ycoords,
d0ycoords,
d1ycoords,
d2ycoords,
d3ycoords,

s0zcoords)
s1zcoords)
s2zcoords)
s3zcoords)
d0zcoords)
d1zcoords)
d2zcoords)
d3zcoords)

#getting to the desired resolution (matching sim dose z res)
desres = 3.0
s0xdiff = round(desres/s0xres, 1)
s0ydiff = round(desres/s0yres, 1)
s0zdiff = round(desres/s0zres, 1)
s1xdiff = round(desres/s1xres, 1)
s1ydiff = round(desres/s1yres, 1)
s1zdiff = round(desres/s1zres, 1)
s2xdiff = round(desres/s2xres, 1)
s2ydiff = round(desres/s2yres, 1)
s2zdiff = round(desres/s2zres, 1)
s3xdiff = round(desres/s3xres, 1)
s3ydiff = round(desres/s3yres, 1)
s3zdiff = round(desres/s3zres, 1)

s0newx = int(round(len(s0xcoords)/(desres/s0xres), 0))
s0newy = int(round(len(s0ycoords)/(desres/s0yres), 0))
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s0newz
s1newx
s1newy
s1newz
s2newx
s2newy
s2newz
s3newx
s3newy
s3newz

=
=
=
=
=
=
=
=
=
=

int(round(len(s0zcoords)/(desres/s0zres),
int(round(len(s1xcoords)/(desres/s1xres),
int(round(len(s1ycoords)/(desres/s1yres),
int(round(len(s1zcoords)/(desres/s1zres),
int(round(len(s2xcoords)/(desres/s2xres),
int(round(len(s2ycoords)/(desres/s2yres),
int(round(len(s2zcoords)/(desres/s2zres),
int(round(len(s3xcoords)/(desres/s3xres),
int(round(len(s3ycoords)/(desres/s3yres),
int(round(len(s3zcoords)/(desres/s3zres),

0))
0))
0))
0))
0))
0))
0))
0))
0))
0))

#resampling surface and dose
s0res, s0resx, s0resy, s0resz = resampSurface(nsurf0,
newz, s0xcoords, s0ycoords, s0zcoords, desres)
s1res, s1resx, s1resy, s1resz = resampSurface(nsurf1,
newz, s1xcoords, s1ycoords, s1zcoords, desres)
s2res, s2resx, s2resy, s2resz = resampSurface(nsurf2,
newz, s2xcoords, s2ycoords, s2zcoords, desres)
s3res, s3resx, s3resy, s3resz = resampSurface(nsurf3,
newz, s3xcoords, s3ycoords, s3zcoords, desres)
d0res = zoom(d0, (d0xres/desres, d0yres/desres,
d0resx = zoom(d0xcoords, d0xres/desres)
d0resy = zoom(d0ycoords, d0yres/desres)
d0resz = zoom(d0zcoords, d0zres/desres)
d1res = zoom(d1, (d1xres/desres, d1yres/desres,
d1resx = zoom(d1xcoords, d1xres/desres)
d1resy = zoom(d1ycoords, d1yres/desres)
d1resz = zoom(d1zcoords, d1zres/desres)
d2res = zoom(d2, (d2xres/desres, d2yres/desres,
d2resx = zoom(d2xcoords, d2xres/desres)
d2resy = zoom(d2ycoords, d2yres/desres)
d2resz = zoom(d2zcoords, d2zres/desres)
d3res = zoom(d3, (d3xres/desres, d3yres/desres,
d3resx = zoom(d3xcoords, d3xres/desres)
d3resy = zoom(d3ycoords, d3yres/desres)
d3resz = zoom(d3zcoords, d3zres/desres)
#cut off
erpolation
d0resx =
d0resy =
d0resz =
d1resx =
d1resy =

s0newx, s0newy, s0
s1newx, s1newy, s1
s2newx, s2newy, s2
s3newx, s3newy, s3

d0zres/desres))

d1zres/desres))

d2zres/desres))

d3zres/desres))

last entry of resampled coordinates since it doesn't extend int
properly
d0resx[0:-1]
d0resy[0:-1]
d0resz[0:-1]
d1resx[0:-1]
d1resy[0:-1]
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d1resz
d2resx
d2resy
d2resz
d3resx
d3resy
d3resz

=
=
=
=
=
=
=

d1resz[0:-1]
d2resx[0:-1]
d2resy[0:-1]
d2resz[0:-1]
d3resx[0:-1]
d3resy[0:-1]
d3resz[0:-1]

#shifting coordinates so 1,2,3 align with sim
thresh = 350
if np.count_nonzero(s1res[:,:,-4]) > thresh:
s1xcshifted, s1ycshifted, s1zcshifted, d1xcshifted, d1ycshifted, d1zcs
hifted = findScalp2(s0res, s1res, s0resx, s0resy, s0resz, s1resx, s1resy,
s1resz, d1resx, d1resy, d1resz)
else:
s0x1, s0x2, s0y1, s0y2, s0z = findScalp(s0res, s0resx, s0resy, s0resz)
s1x1, s1x2, s1y1, s1y2, s1z = findScalp(s1res, s1resx, s1resy, s1resz)
s1xcshifted, s1ycshifted, s1zcshifted, d1xcshifted, d1ycshifted, d1zcs
hifted = shiftCoords(s0x1, s0x2, s0y1, s0y2, s0z, s1x1, s1x2, s1y1, s1y2,
s1z, s1resx, s1resy, s1resz, d1resx, d1resy, d1resz)
if np.count_nonzero(s2res[:,:,-4]) > thresh:
s2xcshifted, s2ycshifted, s2zcshifted, d2xcshifted, d2ycshifted, d2zcs
hifted = findScalp2(s0res, s2res, s0resx, s0resy, s0resz, s2resx, s2resy,
s2resz, d2resx, d2resy, d2resz)
else:
s0x1, s0x2, s0y1, s0y2, s0z = findScalp(s0res, s0resx, s0resy, s0resz)
s2x1, s2x2, s2y1, s2y2, s2z = findScalp(s2res, s2resx, s2resy, s2resz)
s2xcshifted, s2ycshifted, s2zcshifted, d2xcshifted, d2ycshifted, d2zcs
hifted = shiftCoords(s0x1, s0x2, s0y1, s0y2, s0z, s2x1, s2x2, s2y1, s2y2,
s2z, s2resx, s2resy, s2resz, d2resx, d2resy, d2resz)
if np.count_nonzero(s3res[:,:,-4]) > thresh:
s3xcshifted, s3ycshifted, s3zcshifted, d3xcshifted, d3ycshifted, d3zcs
hifted = findScalp2(s0res, s3res, s0resx, s0resy, s0resz, s3resx, s3resy,
s3resz, d3resx, d3resy, d3resz)
else:
s0x1, s0x2, s0y1, s0y2, s0z = findScalp(s0res, s0resx, s0resy, s0resz)
s3x1, s3x2, s3y1, s3y2, s3z = findScalp(s3res, s3resx, s3resy, s3resz)
s3xcshifted, s3ycshifted, s3zcshifted, d3xcshifted, d3ycshifted, d3zcs
hifted = shiftCoords(s0x1, s0x2, s0y1, s0y2, s0z, s3x1, s3x2, s3y1, s3y2,
s3z, s3resx, s3resy, s3resz, d3resx, d3resy, d3resz)
midx = d0res.shape[0]//2
fig = px.imshow(d0res[midx,:,:])
fig.show()
breakpoint()
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d0startx = midx-32
d0stopx = midx+32
y1 = input('starty index?')
y2 = input('stopy index?')
z1 = input('startz index?')
z2 = input('stopz index?')
d0starty = int(y1)
d0stopy = int(y2)
d0startz = int(z1)
d0stopz = int(z2)
d0startxcoord = d0resx[d0startx]
d0stopxcoord = d0resx[d0stopx]
d0startycoord = d0resy[d0starty]
d0stopycoord = d0resy[d0stopy]
d0startzcoord = d0resz[d0startz]
d0stopzcoord = d0resz[d0stopz]
d0xcrop = d0resx[d0startx:d0stopx]
d0ycrop = d0resy[d0starty:d0stopy]
d0zcrop = d0resz[d0startz:d0stopz]
d0crop = d0res[d0startx:d0stopx, d0starty:d0stopy, d0startz:d0stopz]
#crop surfaces and remaining dose maps based on coordinates from sim dos
e crop
s0crop = cropSurface(s0res, s0resx, s0resy, s0resz, d0startxcoord, d0sto
pxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stopzcoord, desres,
'surface')
s1crop = cropSurface(s1res, s1xcshifted, s1ycshifted, s1zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'surface')
s2crop = cropSurface(s2res, s2xcshifted, s2ycshifted, s2zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'surface')
s3crop = cropSurface(s3res, s3xcshifted, s3ycshifted, s3zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'surface')

d1crop = cropSurface(d1res, d1xcshifted, d1ycshifted, d1zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'dose')
d2crop = cropSurface(d2res, d2xcshifted, d2ycshifted, d2zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'dose')
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d3crop = cropSurface(d3res, d3xcshifted, d3ycshifted, d3zcshifted, d0sta
rtxcoord, d0stopxcoord, d0startycoord, d0stopycoord, d0startzcoord, d0stop
zcoord, desres, 'dose')
#write to nrrd file
print(s0crop.shape, s1crop.shape, s2crop.shape, s3crop.shape)
print(d0crop.shape, d1crop.shape, d2crop.shape, d3crop.shape)
nrrd.write(surf0nrrd,s0crop)
nrrd.write(surf1nrrd,s1crop)
nrrd.write(surf2nrrd,s2crop)
nrrd.write(surf3nrrd,s3crop)
nrrd.write(dose0nrrd,d0crop)
nrrd.write(dose1nrrd,d1crop)
nrrd.write(dose2nrrd,d2crop)
nrrd.write(dose3nrrd,d3crop)
return

The following code converts OBJ files to binary masks.
def convertOBJ(surface):
#import surface
surf = pywavefront.Wavefront(surface)
#put vertices into a numpy array
v = np.array(surf.vertices)
#see xv below for explanation
zv = np.unique(v, axis = 0)
zv = zv[:, 0]
#print(np.unique(zv))
diffz = np.round_(zv[1:]-zv[0:-1], decimals = 0)
diffz = max(diffz)
#switch x and y?
v[:,[2,0]] = v[:,[0,2]]
#do the same for y as below with x
yv = np.unique(v, axis = 0)
yv = yv[:,0]
yv = np.unique(yv, axis=0)
diffy = np.round_(yv[1:]-yv[0:-1], decimals = 0)
if max(diffy) == 0:
diffy = 1
else:
diffy = min(diffy[diffy != 0])
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#switch axes again
v[:,[1,0]] = v[:,[0,1]]
#sorts v according to unique elements of x?
xv = np.unique(v, axis = 0)
#take just x elements for array/vector
xv = xv[:,0]
#round the difference between each element in x and the previous element
in x
diffx = np.round_(xv[1:]-xv[0:-1], decimals = 0)
#find the minimum non-zero difference?
diffx = min(diffx[diffx != 0])
#get max x, y, z, values
xmax = max(v[:,0])
xmin = min(v[:,0])
ymax = max(v[:,1])
ymin = min(v[:,1])
zmax = max(v[:,2])
zmin = min(v[:,2])
#get range of x,y,z values
xspan = (xmax-xmin)/diffx
xspan = xspan.astype(int)
yspan = (ymax-ymin)/diffy
yspan = yspan.astype(int)
zspan = (zmax-zmin)/diffz
zspan = zspan.astype(int)

#create regular coordinate grid
x_coords = np.arange(xmin, xmax, diffx)
y_coords = np.arange(ymin, ymax, diffy)
z_coords = np.arange(zmin, zmax+1, diffz)
pixel_data = np.ones((len(x_coords), len(y_coords), len(z_coords)))
coords = {'x': x_coords, 'y': y_coords, 'z': z_coords}
coordGrid = xr.DataArray(pixel_data, dims=('x','y','z'), coords = coords
)
#print(coords)

vlist = v.tolist()

#generate mask
vol = create_mask2(coordGrid, vlist);
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return vol

The following code creates binary masks from a list of coordinates.
def create_mask2(array, contour_list):
'Takes in an Array we want to mask, and a contour'
'coordinate nested list.'
#surf = pywavefront.Wavefront(obj)
#creates array of zeros with same size and shape as array
#mask_array = xr.zeros_like(array)
slice_dict = {}
mask_dict = {}
z = 0
#automatic iteration through contour_list. i is iterating value (0, 1,
2...), coord is the value at that index?
#puts x,y coordinates into slice_dict (essentially reorganizes coordin
ates)
for i, coord in enumerate(contour_list):
'Each list inside contour_list is a list of (x,y,z)'
'coordinates defining the contour on each slice. For each'
'sequence, the z coord is constant. This for-loop builds'
'a numpy array for each series of (x,y) coordinates and'
'stores them in a dict where the corresponding key is the'
'z-coordinate.'
#
x_start = float(array.x[0].values)
y_start = float(array.y[0].values)
spacing = np.round_(float(array.x[1].values) - float(array.x[0].va
lues), decimals = 1)
resized = np.resize(coord, (int(np.size(coord) / 3), 3))
#print(resized)
#print(resized[:,:2])
rtstruct_pixelArray = (resized[:,:2] - [x_start, y_start]) / spaci
ng
rtstruct_pixelArray = np.rint(rtstruct_pixelArray)
#print(rtstruct_pixelArray[0])
#print(coord[2])
#print(type(rtstruct_pixelArray))
#print(type(coord[2]))
if coord[2] != z:
slice_dict[coord[2]] = rtstruct_pixelArray
#print(z)
else:
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#print(slice_dict[coord[2]])
prev = slice_dict[coord[2]]
#print(prev)
#print(rtstruct_pixelArray)
new = np.append(prev, rtstruct_pixelArray, axis = 0)
#print(new)
slice_dict[coord[2]] = new
#breakpoint()
#print(slice_dict)
z = coord[2]
#print(slice_dict.keys())
for z_slc in slice_dict.keys():
'For each z-slice, we need to draw a polygon defined by'
'the points we pulled above. We can do this with ImageDraw.'
polygon = slice_dict[z_slc].flatten().tolist()
#print(polygon)
img = Image.new('1', (array.shape[0], array.shape[1]))
#matplotlib.pyplot.imshow(img)
ImageDraw.Draw(img).polygon(polygon, outline=1, fill=1)
#matplotlib.pyplot.imshow(img)
#breakpoint()
mask = np.array(img)
#print(z_slc, np.sum(mask))
mask_dict[z_slc] = mask
i = -1
mask_vol = xr.zeros_like(array)
mask_dict = dict(sorted(mask_dict.items()))
#print(mask_dict.keys())
#breakpoint()
for z_slc in mask_dict.keys():
'We can reassign values in mask_array with indexing.'
'We rely on sel to give us the slice we need. This works'
'because xarray does not copy the data with sel.'
i += 1
if i > mask_vol.shape[2]-1:
break
#print(i)
#mask_slice = mask_array.sel(z=z_slc, method=None)
#print(mask_slice)
#print(mask_dict)
a = np.swapaxes(mask_dict[z_slc], 0, 1)
#mask_slice[:,:] = mask_dict[z_slc]
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mask_slice = a
mask_vol[:,:,i] = mask_slice
#print(mask_slice)
#final = mask_vol[:,:,0:i]
#print(mask_vol.coords)
#print(mask_vol.shape)
return mask_vol

The following code converts radiation dose files to numpy arrays.
def importDose(dosePath):
#imports dose from rd file and returns xarray as xdose and separated num
py array of dose map and coordinates
ref = pydicom.read_file(dosePath)
coords, dose = pymedphys.dicom.zyx_and_dose_from_dataset(ref)
new_dose = np.swapaxes(dose, 0,2)
xcoords = np.around(np.asarray(coords[2]), decimals = 1)
ycoords = np.around(np.asarray(coords[1]), decimals = 1)
zcoords = np.around(np.asarray(coords[0]), decimals = 1)
dosecoords = {'x': xcoords, 'y': ycoords, 'z': zcoords}
xdose = xr.DataArray(new_dose, dims=('x','y','z'), coords = dosecoords)
return xdose, new_dose, xcoords, ycoords, zcoords

The following code separates coordinates and data from Python data arrays.
def xyz_and_numpy_from_xarray(xarray):
#separates numpy array and coordinates out of xarray
xcoord = xr.DataArray.to_numpy(xarray.coords['x'])
ycoord = xr.DataArray.to_numpy(xarray.coords['y'])
zcoord = xr.DataArray.to_numpy(xarray.coords['z'])
array = xr.DataArray.to_numpy(xarray)
return array, xcoord, ycoord, zcoord

The following code obtains the resolution of coordinate lists.
def getxyzRes(xcoord, ycoord, zcoord):
#gets resolution of x,y,z coordinates
xres = round((xcoord[-1] - xcoord[0])/len(xcoord), 1)
yres = round((ycoord[-1] - ycoord[0])/len(ycoord), 1)
zres = round((zcoord[-1] - zcoord[0])/len(zcoord), 0)
return xres, yres, zres
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The following code resamples the binary surface mask.
def resampSurface(surfArray, newx, newy, newz, xcoords, ycoords, zcoords,
dzres):
#resamples the array and coordinates to dzres
resampsxyVol = np.zeros((newx, newy, len(zcoords)))
for z in range(surfArray.shape[2]):
resampsxyVol[:,:,z] = cv2.resize(surfArray[:,:,z], (newy, newx), inter
polation=cv2.INTER_NEAREST)
resampsVol = np.zeros((newx, newy, newz))
if dzres ==3:
for z in range(surfArray.shape[2]):
resampsVol[:,:,2*z] = resampsxyVol[:,:,z]
resampsVol[:,:,2*z+1] = resampsxyVol[:,:,z]
rszcoords = np.around(np.arange(zcoords[0],zcoords[1]+2*dzres,dzres), decimals=1)
elif dzres ==2:
for z in range(surfArray.shape[2]):
resampsVol[:,:,3*z] = resampsxyVol[:,:,z]
resampsVol[:,:,3*z+1] = resampsxyVol[:,:,z]
resampsVol[:,:,3*z+2] = resampsxyVol[:,:,z]
rszcoords = np.around(np.arange(zcoords[0],zcoords[1]+3*dzres,dzres), decimals=1)
rsxcoords = np.around(np.arange(xcoords[0],xcoords[1]+dzres,dzres), decimals=1)
rsycoords = np.around(np.arange(ycoords[0],ycoords[1]+dzres,dzres), decimals=1)
return resampsVol, rsxcoords, rsycoords, rszcoords

The following code finds the superior extent of the anatomy in a surface array, if the top of the
skull is included in the array.
def findScalp(array, xcoords, ycoords, zcoords):
#finds the scalp in a surface array if the top of the surface includes t
he scalp
for z in reversed(range(array.shape[2])):
if np.sum(array[:,:,z]) > 0:
nz = np.nonzero(array[:,:,z])
x1 = min(nz[0])
x2 = max(nz[0])
y1 = min(nz[1])
y2 = max(nz[1])
zin = z
break
startx = xcoords[x1]
stopx = xcoords[x2]
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starty = ycoords[y1]
stopy = ycoords[y2]
zc = zcoords[zin]
return startx, stopx, starty, stopy, zc

The following code matches two surface arrays if the top of the skull is not included in the
surface array.
def findScalp2(array0, array1, x0coords, y0coords, z0coords, sx1coords, sy
1coords, sz1coords, dx1coords, dy1coords, dz1coords):
#shifts coordinates for a given surface (1,2,3) to align with surface 0
by trying to find slices where the size of the head matches
#print(np.count_nonzero(array1[:,:,-1]))
nz = np.nonzero(array1[:,:,-4])
x1 = min(nz[0])
x2 = max(nz[0])
y1 = min(nz[1])
y2 = max(nz[1])
width1 = x2-x1
#print(width1)
startx1 = sx1coords[x1]
stopx1 = sx1coords[x2]
starty1 = sy1coords[y1]
stopy1 = sy1coords[y2]
zc1 = sz1coords[-1]
for z in reversed(range(array0.shape[2])):
nz0 = np.nonzero(array0[:,:,z])
width0 = max(nz0[0])-min(nz0[0])
if width0 > width1:
if z == array0.shape[2]-1:
zin = z
x01 = min(nz0[0])
x02 = max(nz0[0])
y01 = min(nz0[1])
y02 = max(nz0[1])
#print(np.nonzero(array0[:,:,z]))
#print(np.nonzero(array0[:,:,z+1]))
else:
nzprev = np.nonzero(array0[:,:,z+1])
width0prev = max(nzprev[0])-min(nzprev[0])
#print(z)
if min(abs(width0-width1), abs(width0prev-width1)) == abs(width0width1):
zin = z
x01 = min(nz0[0])
x02 = max(nz0[0])
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y01 = min(nz0[1])
y02 = max(nz0[1])
else:
zin = z+1
x01 = min(nzprev[0])
x02 = max(nzprev[0])
y01 = min(nzprev[1])
y02 = max(nzprev[1])
break
startx0 = x0coords[x01]
stopx0 = x0coords[x02]
starty0 = y0coords[y01]
stopy0 = y0coords[y02]
zc0 = z0coords[zin]
xshift = ((startx0-startx1)+(stopx0-stopx1))/2
yshift = ((starty0-starty1)+(stopy0-stopy1))/2
zshift = zc0-zc1
shifteddxc = dx1coords + xshift
shifteddyc = dy1coords + yshift
shifteddzc = dz1coords + zshift
shiftedsxc = sx1coords + xshift
shiftedsyc = sy1coords + yshift
shiftedszc = sz1coords + zshift
return shiftedsxc, shiftedsyc, shiftedszc, shifteddxc, shifteddyc, shift
eddzc, xshift, yshift, zshift

The following code shifts surface and dose coordinates to ensure alignment.
def shiftCoords(s0x1, s0x2, s0y1, s0y2, s0z, s1x1, s1x2, s1y1, s1y2, s1z,
sxcoords, sycoords, szcoords, dxcoords, dycoords, dzcoords):
#shifts coordinates if the top of the head is included in the scan to al
ign the surface and dose with the sim
xshift = ((s0x1-s1x1)+(s0x2-s1x2))/2
yshift = ((s0y1-s1y1)+(s0y2-s1y2))/2
zshift = s0z-s1z
shifteddxc = dxcoords + xshift
shifteddyc = dycoords + yshift
shifteddzc = dzcoords + zshift
shiftedsxc = sxcoords + xshift
shiftedsyc = sycoords + yshift
shiftedszc = szcoords + zshift
return shiftedsxc, shiftedsyc, shiftedszc, shifteddxc, shifteddyc, shift
eddzc, xshift, yshift, zshift
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The following code crops the surface and dose arrays
def cropSurface(surfArray, xcoords, ycoords, zcoords, startxcoord, stopxco
ord, startycoord, stopycoord, startzcoord, stopzcoord, dzres, type):
#crops surface (or dose) based on matching coordinates to the dose crop
xstartdiff = np.absolute(xcoords-startxcoord)
surfxstartindex = xstartdiff.argmin()
xstopdiff = np.absolute(xcoords-stopxcoord)
surfxstopindex = xstopdiff.argmin()
ystartdiff = np.absolute(ycoords-startycoord)
surfystartindex = ystartdiff.argmin()
if stopycoord > ycoords[-1] +2.5:
ystopdiff = np.absolute(stopycoord-ycoords[-1])
surfystopindex = int(round(ystopdiff/dzres, 0) + len(ycoords)-1)
else:
ystopdiff = np.absolute(ycoords - stopycoord)
surfystopindex = ystopdiff.argmin()
zstartdiff = np.absolute(zcoords-startzcoord)
surfzstartindex = zstartdiff.argmin()
zstopdiff = np.absolute(zcoords-stopzcoord)
surfzstopindex = zstopdiff.argmin()
#print(surfxstartindex, surfxstopindex, surfystartindex, surfystopindex,
surfzstartindex, surfzstopindex)
if surfxstopindex - surfxstartindex < 64:
if surfxstopindex - surfxstartindex == 63:
if surfxstartindex == 0:
surfxstopindex += 1
elif abs(xcoords[surfxstartindex]-xcoords[surfxstartindex1]) < abs(xcoords[surfxstopindex]+xcoords[surfxstopindex+1]):
surfxstartindex = surfxstartindex - 1
elif abs(xcoords[surfxstartindex]-xcoords[surfxstartindex1]) > abs(xcoords[surfxstopindex]+xcoords[surfxstopindex+1]):
surfxstopindex += 1
elif surfxstopindex - surfxstartindex == 62 and surfxstartindex != 0:
surfxstartindex = surfxstartindex - 1
surfxstopindex = surfxstopindex + 1
elif surfxstopindex - surfxstartindex == 62 and surfxstartindex == 0:
surfxstopindex = surfxstopindex + 2
if surfxstopindex - surfxstartindex > 64:
if xstopdiff.argmin() > xstartdiff.argmin():
surfxstartindex += 1
else:
surfxstopindex += -1
if surfystopindex - surfystartindex < 64:
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if surfystopindex - surfystartindex == 63:
if surfystopindex > len(ycoords)-1:
surfystopindex += 1
else:
if surfystartindex == 0:
surfystopindex += 1
elif abs(ycoords[surfystartindex]-ycoords[surfystartindex1]) < abs(ycoords[surfystopindex]+ycoords[surfystopindex+1]):
surfystartindex = surfystartindex - 1
elif abs(ycoords[surfystartindex]-ycoords[surfystartindex1]) > abs(ycoords[surfystopindex]+ycoords[surfystopindex+1]):
surfystopindex += 1
elif surfystopindex - surfystartindex == 62 and surfystartindex
surfystartindex = surfystartindex - 1
surfystopindex = surfystopindex + 1
elif surfystopindex - surfystartindex == 62 and surfystartindex
surfystopindex = surfystopindex + 2
elif surfystopindex - surfystartindex == 61 and surfystartindex
surfystartindex = surfystartindex - 1
surfystopindex = surfystopindex + 2
elif surfystopindex - surfystartindex == 61 and surfystartindex
surfystopindex = surfystopindex + 3
if surfystopindex - surfystartindex > 64:
if ystopdiff.argmin() > ystartdiff.argmin():
surfystartindex += 1
else:
surfystopindex = surfystopindex - 1

!= 0:

== 0:
!= 0:

== 0:

if surfzstopindex - surfzstartindex < 64:
if surfzstopindex - surfzstartindex == 63:
if surfzstartindex == 0:
surfzstopindex += 1
elif abs(zcoords[surfzstartindex]-zcoords[surfzstartindex1]) < abs(zcoords[surfzstopindex]+zcoords[surfzstopindex+1]):
surfzstartindex = surfzstartindex - 1
elif abs(zcoords[surfzstartindex]-zcoords[surfzstartindex1]) > abs(zcoords[surfzstopindex]+zcoords[surfzstopindex+1]):
surfzstopindex += 1
elif surfzstopindex - surfzstartindex == 62 and surfzstartindex != 0:
surfzstartindex = surfzstartindex - 1
surfzstopindex = surfzstopindex + 1
elif surfzstopindex - surfzstartindex == 62 and surfzstartindex == 0:
surfzstopindex = surfzstopindex + 2
elif surfzstopindex - surfzstartindex > 64:
if zstopdiff.argmin() > zstartdiff.argmin():
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surfzstartindex += 1
else:
surfzstopindex = surfzstopindex - 1
if type == 'surface':
surfcrop = np.zeros((surfxstopindex-surfxstartindex, surfystopindexsurfystartindex, surfzstopindex-surfzstartindex))
#print(surfArray.shape)
for y in range(surfArray.shape[1]-surfystartindex):
if y == surfcrop.shape[1]:
break
else:
surfcrop[:,y,:] = surfArray[surfxstartindex:surfxstopindex, surfys
tartindex+y, surfzstartindex:surfzstopindex]
else:
surfcrop = surfArray[surfxstartindex:surfxstopindex, surfystartindex:s
urfystopindex, surfzstartindex:surfzstopindex]
return surfcrop, surfxstartindex, surfystartindex, surfzstartindex

B.3.2 Neural Network
The following code prepares the data for input to the network.
class surfaceDoseData(keras.utils.Sequence):
def __init__(self, batch_size, img_size, input_img_paths, target_img_pat
hs):
self.batch_size = batch_size
self.img_size = img_size
self.input_img_paths = input_img_paths
self.target_img_paths = target_img_paths
def __len__(self):
return len(self.target_img_paths) // self.batch_size
def __getitem__(self, idx):
i = idx * self.batch_size
batch_input_img_paths = self.input_img_paths[i:i+self.batch_size]
batch_target_img_paths = self.target_img_paths[i:i+self.batch_size]
x = np.zeros((self.batch_size, )+ self.img_size + (3,))
for j, path in enumerate(batch_input_img_paths):
#print(path)
surface0, header = nrrd.read('/content/drive/MyDrive/Colab/HNSI/Cent
erCrop/Surface/' + '0/' + path.split('/')[1] + '.nrrd')
surfacex, header = nrrd.read('/content/drive/MyDrive/Colab/HNSI/Cent
erCrop/Surface/' + path + '.nrrd')
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dose0, header = nrrd.read('/content/drive/MyDrive/Colab/HNSI/CenterC
rop/Dose/' + '0/' + path.split('/')[1] + '.nrrd')
dose0norm = dose0/100

x[j] = np.stack((surface0, surfacex, dose0norm), axis=-1)
y = np.zeros((self.batch_size,) + self.img_size)
for j, path in enumerate(batch_target_img_paths):
dosex, header = nrrd.read('/content/drive/MyDrive/Colab/HNSI/CenterC
rop/Dose/' + path + '.nrrd')
dosexnorm = dosex/100

y[j] = dosexnorm
return x, y

The following code is the network.
def unetconv1(sz = (64, 64, 64, 3)):
x = tf.keras.Input(sz)
inputs = x
### [First half of the network: downsampling inputs] ###
layers = []
# Entry block
x = tf.keras.layers.Conv3D(16, (3, 3, 3), padding = 'same', activation='
relu', input_shape=(64, 64, 64, 3))(x)
x = tf.keras.layers.Conv3D(16, (3, 3, 3), padding = 'same', activation='
relu')(x)
layers.append(x)
#print(x.shape)
x = tf.keras.layers.MaxPooling3D()(x)

# Blocks 1, 2, 3 are identical apart from the feature depth.
for filters in [32, 64, 128]:
x = tf.keras.layers.Conv3D(filters, (3, 3, 3), padding = 'same', activ
ation='relu')(x)
x = tf.keras.layers.Conv3D(filters, (3, 3, 3), padding = 'same', activ
ation='relu')(x)
layers.append(x)
print(x.shape)
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x = tf.keras.layers.MaxPooling3D()(x)
j = len(layers) - 1
x = tf.keras.layers.Conv3D(256, (3, 3, 3), padding = 'same', activation=
'relu')(x)
x = tf.keras.layers.Conv3D(256, (3, 3, 3), padding = 'same', activation=
'relu')(x)
x = tf.keras.layers.Conv3D(256, (3, 3, 3), padding = 'same', activation=
'relu')(x)
x = tf.keras.layers.Conv3D(256, (3, 3, 3), padding = 'same', activation=
'relu')(x)
#print(x.shape)
x = tf.keras.layers.Conv3DTranspose(128, 2, strides = 2, activation='rel
u')(x)
#print(x.shape)
x = tf.keras.layers.Concatenate(axis=4)([x, layers[j]])
#print('after 1 concat', x.shape)
j = j -1
### [Second half of the network: upsampling inputs] ###
for filters in [128, 64, 32]:
x = tf.keras.layers.Conv3D(filters, (3, 3, 3), padding = 'same', activ
ation='relu')(x)
x = tf.keras.layers.Conv3D(filters, (3, 3, 3), padding = 'same', activ
ation='relu')(x)
x = tf.keras.layers.Conv3DTranspose(filters/2, 2, strides = 2, activat
ion='relu')(x)
#print(x.shape)
x = tf.keras.layers.Concatenate(axis=4)([x, layers[j]])
#print(x.shape)
j = j-1
x = tf.keras.layers.Conv3D(16, (3, 3, 3), padding = 'same', activation='
relu')(x)
x = tf.keras.layers.Conv3D(16, (3, 3, 3), padding = 'same', activation='
relu')(x)
outputs = tf.keras.layers.Conv3D(1, (1,1,1), padding = 'same', activatio
n='relu')(x)
print(outputs.shape)
# Add a per-pixel classification layer
#outputs = layers.Conv2D(num_classes, 3, activation="softmax", padding="
same")(x)
# Define the model
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model = tf.keras.Model(inputs, outputs)
return model

B.3.3 Dose Prediction Analysis
The following script was used for evaluation of the network.
truearray, headert = nrrd.read('/content/drive/MyDrive/Colab/HNSI/CenterCr
op/Dose/3/1.nrrd')
predarray, headerp = nrrd.read('/content/drive/MyDrive/Colab/HNSI/AllTrain
Predictions/3-1/Pt1CBCT3Pred.nrrd')
rx = 69.96
predarray = predarray*100
maxpred = np.amax(predarray)
maxtrue = np.amax(truearray)
print('True max is', maxtrue, 'Gy. Predicted max is', maxpred, 'Gy.')
truearray001 = truearray*(truearray >= 0.001)
predarray001 = predarray*(predarray >= 0.001)
meanpred = np.sum(predarray)/np.count_nonzero(predarray)
meantrue = np.sum(truearray001)/np.count_nonzero(truearray >= 0.001)
#meanpred = np.mean(predarray)
#meantrue = np.mean(truearray)
print('True mean is', meantrue, 'Gy. Predicted mean is', meanpred, 'Gy.')
rmse = np.sqrt(((predarray - truearray)**2).mean())
mae = np.mean(np.abs(truearray - predarray))
print('RMSE is', rmse, '. MAE is', mae)
#V100 DSC
v100true = np.copy(truearray)
v100pred = np.copy(predarray)
v100true[v100true
v100true[v100true
v100pred[v100pred
v100pred[v100pred

< rx] = 0
>= rx] = 1
< rx] = 0
>= rx] = 1

v100true.astype(bool)
v100pred.astype(bool)
intersection = np.logical_and(v100true, v100pred)
dsc100 = 2. * intersection.sum() / (v100true.sum() + v100pred.sum())
print('The DSC between the true V100 and the predicted V100 is', dsc100)
vol100true = np.count_nonzero(v100true)*27/1000
vol100pred = np.count_nonzero(v100pred)*27/1000
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print('The volume of the true V100 is', vol100true, 'cc. The volume of the
predicted V100 is', vol100pred, 'cc.')
#V95 DSC
v95true = np.copy(truearray)
v95pred = np.copy(predarray)
thresh = 0.95*rx
v95true[v95true
v95true[v95true
v95pred[v95pred
v95pred[v95pred

< thresh] = 0
>= thresh] = 1
< thresh] = 0
>= thresh] = 1

v95true.astype(bool)
v95pred.astype(bool)
intersection = np.logical_and(v95true, v95pred)
dsc95 = 2. * intersection.sum() / (v95true.sum() + v95pred.sum())
print('The DSC between the true V95 and the predicted V95 is', dsc95)
#V90 DSC
v90true = np.copy(truearray)
v90pred = np.copy(predarray)
thresh = 0.90*rx
v90true[v90true
v90true[v90true
v90pred[v90pred
v90pred[v90pred

< thresh] = 0
>= thresh] = 1
< thresh] = 0
>= thresh] = 1

v90true.astype(bool)
v90pred.astype(bool)
intersection = np.logical_and(v90true, v90pred)
dsc90 = 2. * intersection.sum() / (v90true.sum() + v90pred.sum())
print('The DSC between the true V90 and the predicted V90 is', dsc90)
vol90true = np.count_nonzero(v90true)*27/1000
vol90pred = np.count_nonzero(v90pred)*27/1000
print('The volume of the true V90 is', vol90true, 'cc. The volume of the p
redicted V90 is', vol90pred, 'cc.')
#V70 DSC
v70true = np.copy(truearray)
v70pred = np.copy(predarray)
thresh = 0.70*rx
v70true[v70true < thresh] = 0
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v70true[v70true >= thresh] = 1
v70pred[v70pred < thresh] = 0
v70pred[v70pred >= thresh] = 1
v70true.astype(bool)
v70pred.astype(bool)
intersection = np.logical_and(v70true, v70pred)
dsc70 = 2. * intersection.sum() / (v70true.sum() + v70pred.sum())
print('The DSC between the true V70 and the predicted V70 is', dsc70)
#V50 DSC
v50true = np.copy(truearray)
v50pred = np.copy(predarray)
thresh = 0.50*rx
v50true[v50true
v50true[v50true
v50pred[v50pred
v50pred[v50pred

< thresh] = 0
>= thresh] = 1
< thresh] = 0
>= thresh] = 1

v50true.astype(bool)
v50pred.astype(bool)
intersection = np.logical_and(v50true, v50pred)
dsc50 = 2. * intersection.sum() / (v50true.sum() + v50pred.sum())
print('The DSC between the true V50 and the predicted V50 is', dsc50)
#V20 DSC
v20true = np.copy(truearray)
v20pred = np.copy(predarray)
thresh = 0.20*rx
v20true[v20true
v20true[v20true
v20pred[v20pred
v20pred[v20pred

< thresh] = 0
>= thresh] = 1
< thresh] = 0
>= thresh] = 1

v20true.astype(bool)
v20pred.astype(bool)
intersection = np.logical_and(v20true, v20pred)
dsc20 = 2. * intersection.sum() / (v20true.sum() + v20pred.sum())
print('The DSC between the true V20 and the predicted V20 is', dsc20)
#V10 DSC
v10true = np.copy(truearray)
v10pred = np.copy(predarray)
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thresh = 0.10*rx
v10true[v10true
v10true[v10true
v10pred[v10pred
v10pred[v10pred

< thresh] = 0
>= thresh] = 1
< thresh] = 0
>= thresh] = 1

v10true.astype(bool)
v10pred.astype(bool)
intersection = np.logical_and(v10true, v10pred)
dsc10 = 2. * intersection.sum() / (v10true.sum() + v10pred.sum())
print('The DSC between the true V10 and the predicted V10 is', dsc10)
#True V100 overlaid on predicted dose map: mean and is the max inside
v100td = v100true*truearray
v100pd = v100true*predarray
v100tnonzero = np.count_nonzero(v100td)
v100pnonzero = np.count_nonzero(v100pd)
v100tmean = np.sum(v100td)/v100tnonzero
v100pmean = np.sum(v100pd)/v100pnonzero
print('The mean of the true V100 is', v100tmean, 'Gy. The mean of the pred
icted V100 is', v100pmean, 'Gy.')
print('The predicted max is within the true V100 volume:', np.amax(v100pd)
== maxpred)
#True V95 overlaid on predicted dose map: mean
v95td = v95true*truearray
v95pd = v95true*predarray
v95tnonzero = np.count_nonzero(v95td)
v95pnonzero = np.count_nonzero(v95pd)
v95tmean = np.sum(v95td)/v95tnonzero
v95pmean = np.sum(v95pd)/v95pnonzero
print('The mean of the true V95 is', v95tmean, 'Gy. The mean of the predic
ted V95 is', v95pmean, 'Gy.')
#True V90 overlaid on predicted dose map: mean
v90td = v90true*truearray
v90pd = v90true*predarray
v90tnonzero = np.count_nonzero(v90td)
v90pnonzero = np.count_nonzero(v90pd)
v90tmean = np.sum(v90td)/v90tnonzero
v90pmean = np.sum(v90pd)/v90pnonzero
print('The mean of the true V90 is', v90tmean, 'Gy. The mean of the predic
ted V90 is', v90pmean, 'Gy.')
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#True V70 overlaid on predicted dose map: mean
v70td = v70true*truearray
v70pd = v70true*predarray
v70tnonzero = np.count_nonzero(v70td)
v70pnonzero = np.count_nonzero(v70pd)
v70tmean = np.sum(v70td)/v70tnonzero
v70pmean = np.sum(v70pd)/v70pnonzero
print('The mean of the true V70 is', v70tmean, 'Gy. The mean of the predic
ted V70 is', v70pmean, 'Gy.')

bins = range(1, math.ceil(maxtrue))
truehist100 = np.zeros(math.ceil(maxtrue))
predhist100 = np.zeros(math.ceil(maxtrue))
truehist95 = np.zeros(math.ceil(maxtrue))
predhist95 = np.zeros(math.ceil(maxtrue))
truehist90 = np.zeros(math.ceil(maxtrue))
predhist90 = np.zeros(math.ceil(maxtrue))
truehist70 = np.zeros(math.ceil(maxtrue))
predhist70 = np.zeros(math.ceil(maxtrue))
for i in bins:
truehist100[i] = np.count_nonzero(v100td >= i)/np.count_nonzero(v100td)
predhist100[i] = np.count_nonzero(v100pd >= i)/np.count_nonzero(v100pd)
truehist95[i] = np.count_nonzero(v95td >= i)/np.count_nonzero(v95td)
predhist95[i] = np.count_nonzero(v95pd >= i)/np.count_nonzero(v95pd)
truehist90[i] = np.count_nonzero(v90td >= i)/np.count_nonzero(v90td)
predhist90[i] = np.count_nonzero(v90pd >= i)/np.count_nonzero(v90pd)
truehist70[i] = np.count_nonzero(v70td >= i)/np.count_nonzero(v70td)
predhist70[i] = np.count_nonzero(v70pd >= i)/np.count_nonzero(v70pd)
plt.plot(truehist100, color = 'darkred', label = 'True V100')
plt.plot(predhist100, color = 'red', linestyle = 'dashed', label = 'Predic
ted V100')
plt.plot(truehist95, color = 'darkgoldenrod', label = 'True V95')
plt.plot(predhist95, color = 'gold', linestyle = 'dashed', label = 'Predic
ted V95')
plt.plot(truehist90, color = 'darkgreen', label = 'True V90')
plt.plot(predhist90, color = 'lime', linestyle = 'dashed', label = 'Predic
ted V90')
plt.plot(truehist70, color = 'navy', label = 'True V70')
plt.plot(predhist70, color = 'cornflowerblue', linestyle = 'dashed', label
= 'Predicted V70')
plt.xlim(60, 85)
plt.title('DVH for Various Dose-Volumes')
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plt.xlabel('Absolute Dose (Gy)')
plt.ylabel('Volume (%)')
plt.legend(loc = 'best')
plt.savefig('/content/drive/MyDrive/Colab/HNSI/AllTrainPredictions/31/DoseVolDVHTail.png', dpi = 300, format = 'png')
#plt.show()
#plt.imshow(predarray[:,:,30], cmap = 'jet', vmin=0, vmax=78)
#plt.colorbar()
#plt.imshow(v90pred[:,:,40], cmap = 'gray')
#plt.savefig('/content/drive/MyDrive/Colab/HNSI/AllTrainPredictions/346/PredDoseMap.png', dpi = 300, format = 'png')
#plt.imshow(predarray[:,:,30]-truearray[:,:,30], cmap = 'bwr', vmin = 25, vmax = 25)
#plt.colorbar()
#plt.savefig('/content/drive/MyDrive/Colab/HNSI/AllTrainPredictions/346/DoseDiff.png', dpi = 300, format = 'png')
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Abstract

Background: Growing in popularity, adaptive radiotherapy therapy (ART) has the potential to
improve outcomes and reduce side effects for patients. However, determining if/when a patient
may benefit from ART remains difficult. Deformable image registration (DIR) between the
planning CT and daily CBCT images can enable estimation of delivered dose and aid in this
decision-making process. Yet, this task is complicated by inaccurate Hounsfield Units (HUs) and
limited field-of-view (FOV) of CBCT.
Purpose: This work developed and validated an open-source DIR algorithm for CT-to-CBCT
registration which addressed the primary challenges facing this registration problem.
Methods: Twenty-five retrospectively selected head and neck (HN) patients, exhibiting various
levels of weight loss during their treatment course, were chosen for the study. Several important
CBCT preprocessing steps aided in overcoming the key challenges for the registration. Fifteen
patients were used to develop the algorithm based on the open-source software Elastix.
Parameterization of the algorithm relied on qualitative inspection of registrations. The remaining
ten patients were used for validation of the algorithm which was based on Dice similarity
coefficient (DSC), Jaccard index (JI), and Hausdorff distance (HD) for mandible, spinal cord,
and parotids.
Results: Across all ten validation patients, the DSC was 0.78 and 0.71 for bony anatomy and
soft tissue, respectively. The JI was 0.65 and 0.56, and the HD was 4.4mm and 3.6mm, for bony
anatomy and soft tissue, respectively.
Conclusions: The developed method resulted in sufficient accuracy for the task of delivered
dose calculation to inform ART decision making.
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Introduction
Image guidance is a key tool in radiotherapy, improving geometric accuracy and allowing
for advanced treatment techniques, such as adaptive radiotherapy (ART).
In head and neck (HN) treatments in particular, ART has been explored to address the
significant anatomic changes commonly encountered over the course of treatment. Apart from
intended tumor volume shrinkage, studies have reported marked reduction in parotid glands
size1,2, and overall weight loss from side effects like xerostomia, dysphagia, and loss of taste3.
These anatomic changes have been linked to differences between delivered and planned doses,
including increased hot spots, reduced target coverage, and increased dose to organs at risk
(OARs)4–7. This has prompted research to determine what patients benefit most from ART. Some
studies have used pretreatment indicators as predictors, with some success8–11. One study used
deformable image registration (DIR) between the pCT and the CBCT to recalculate the dose at
each fraction, which led to no missed necessary replans and fewer unnecessary ones12. Using
DIR to deform the pCT to the CBCT is complicated, amongst other factors, by the limited CBCT
FOV. In this study, we developed and validated a method for deforming a pCT to a CBCT
without sacrificing the pCT field of view using an open-source DIR algorithm.
Methods
Patient Data
Fifteen HN patients with one pCT and three CBCTs each were retrospectively selected to
develop the registration method. Patients were treated on a Truebeam Linac (Varian Medical
Systems, Palo Alto, CA). Only patients with anatomic changes visible on CBCT were chosen.
Ten additional HN patients with the same criteria were retrospectively chosen to evaluate
the registration method. A single CBCT from each patient with a large anatomic change relative
to their pCT was chosen.
DIR Method
The developed method was implemented using a combination of MATLAB
(Mathworks, Natick, MA) and elastix, an open-source DIR algorithm13. The pCT and CBCT
were exported from MIM in mhd format. MATLAB scripts resampled and padded the CBCTs
with air to the resolution and approximate size of the corresponding pCTs. Binary masks
corresponding to the FOV of the CBCT were created to ensure the algorithm only used
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information inside the FOV for calculating the rigid and deformable registration. Each
registration (rigid transform followed by a B-spline transform) was completed in elastix.

Image Pyramid
Sampler
Interpolator
Optimizer
Transform
Similarity Metric
Regularization Term

Rigid
Gaussian Pyramid
Random
B-Spline
Adaptive Stochastic Gradient Descent
Euler Transform
Normalized Correlation Coefficient

Deformable
Gaussian Pyramid
Random Coordinate
B-Spline
Adaptive Stochastic Gradient Descent
B-Spline
Mutual Information
Bending Energy Penalty

Table 1 Parameters used for rigid and deformable registration in elastix. The weights
assigned to the mutual information metric and bending energy penalty were 1 and 25,
respectively.
Registration parameters are shown in Table 1 and were based on those used in another
study14. Deformable registration was performed using a B-spline transformation basis, defined
by a uniform grid of control points overlaid on the fixed image (CBCT). Since a mask is
equipped to indicate the CBCT FOV as the region of interest, the B-spline grid extends just
outside of the mask, where the calculated transformation quickly goes to zero. Thus the
anatomical information outside of the CBCT FOV in the dCT is not deformed but rigidly
registered. The registration was performed with an anisotropic, multi-resolution image pyramid,
such that in each of the three resolutions used, the superior-inferior dimension had less
downsampling to account for the larger spacing inherent to the images. The deformable portion
of the registration algorithm used a combination of local mutual information (similarity metric)
and a bending energy penalty (regularization) term. The bending energy penalty term penalizes
abrupt changes in the transformation to prevent the deformation from becoming irregular or
folding in on itself. Weights for the two metrics were updated to improve performance on this
dataset, and it was concluded that the two metrics in combination were superior to mutual
information alone, after investigations with a single parameter resulted in inaccurate and
excessive deformation.
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Fig 1: DIR flowchart
During development, the registration quality was assessed using the Jacobian map of the
deformation vector field and visual inspection. Following a successful registration, a MATLAB
script converted the dCT from the mhd image format used by elastix to DICOM for importing
back to the treatment planning system (TPS).
Validating the DIR Method
The deformation method was evaluated through contour analysis. Contours were drawn
on the CBCT by expert physicians. Parotids, mandible, and spinal cord were chosen due to their
importance in treatment planning and outcomes. Planning CT contours were deformed according
to their respective dCT transform parameters. Dice similarity coefficient (DSC), Jaccard Index
(JI), and Hausdorff distance (HD) were used to quantitatively compare the deformed contours to
the CBCT contours.
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Fig 2: Axial, coronal, and sagittal views of the pCT, CBCT, dCT, rigid registration of the pCT
to the CBCT, and rigid registration of the dCT to the CBCT.

Results
Upon visual inspection, the registrations and resultant dCTs appeared reasonable (see
Figure 2). The DSC, JI, and HD results are summarized in Table 2.
The DSC values are 0.78 and 0.71 for bony anatomy and soft tissue, respectively. The JI
values are 0.65 and 0.56, respectively. The DSC and JI for the mandible significantly (p=0.002,
Student’s t-test) outperformed that for the cord. The HD are 4.4mm and 3.6mm for bony
anatomy and soft tissue, respectively.
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Mandible
Cord
Left Parotid
Right Parotid
DSC
JI
HD DSC
JI
HD DSC
JI
HD DSC
JI
HD
Pt1
0.70 0.55 5.1 0.83 0.71 2.4 0.71 0.56 4.1 N/A N/A N/A
Pt2
0.85 0.73 5.8 0.71 0.55 3.9 0.62 0.45 3.1 0.50 0.33 3.3
Pt3
0.82 0.69 7.5 0.69 0.53 2.9 0.78 0.64 3.3 0.81 0.67 3.5
Pt4
0.78 0.65 4.9 0.75 0.59 2.4 0.67 0.50 3.5 0.39 0.24 4.1
Pt5
0.87 0.77 6.1 0.74 0.59 2.6 0.77 0.63 3.1 0.82 0.69 3.7
Pt6
0.88 0.78 4.4 0.73 0.57 4.6 0.75 0.60 3.9 0.77 0.63 3.5
Pt7
0.90 0.82 4.1 0.71 0.56 2.6 0.79 0.66 2.6 0.80 0.66 3.7
Pt8
0.86 0.76 6.1 0.77 0.62 3.1 0.83 0.72 3.7 0.78 0.64 3.7
Pt9
0.80 0.67 7.3 0.67 0.51 2.9 0.68 0.51 3.5 0.72 0.56 4.3
Pt10 0.75 0.61 6.9 0.81 0.68 2.6 0.55 0.38 3.1 0.65 0.48 4.1
Mean 0.82 0.70 5.8 0.74 0.59 3.0 0.72 0.56 3.4 0.69 0.55 3.8
Stdev 0.06 0.08 1.1 0.05 0.06 0.7 0.08 0.10 0.4 0.14 0.15 0.3
Min 0.71 0.55 4.1 0.67 0.51 2.4 0.55 0.38 2.6 0.39 0.24 3.3
Max 0.90 0.82 7.5 0.83 0.82 4.6 0.83 0.72 4.1 0.82 0.69 4.3
Table 2 Dice similarity coefficient (DSC), Jaccard index (JI), and Hausdorff distance (HD)
resultsfor CBCT and deformed contours from the pCT for 10 patients. HD is reported in mm.
Discussion
We developed a deformable registration method to register a pCT to a CBCT which
solved several common issues encountered for this task, including limited FOV and inaccurate
Hounsfield Unit values.
The results for all contours are comparable to previous publications. While TG-132 sets a
goal of achieving DSC of 0.8-0.9 for validating image registration methods, this is not
achievable for all structures. Commercial algorithms have been found to fall short, specifically in
HN, with an average DSC of 0.73 for HN OARs in one study directly assessing TG-132
recommendations15. In-house algorithms have achieved similar results, with reported DSC values
of 0.85 for bony anatomy and 0.79 for soft tissue, or 0.83, 0.79, 0.74, and 0.72 for the mandible,
spinal cord, and left and right parotid, specifically, and reported HD values ranging from 2.00 to
5.19 mm over soft tissue and bony anatomy16–18. However, these studies had crucial differences
from this study including imaging modality, number of observers, and contour selection. A
study investigating interobserver variability on HN CT found average DSC values of 0.90, 0.78,
0.82, and 0.83 for mandible, spinal cord, and left and right parotid, respectively, with a large
majority of the observers following the same guidelines for all contours apart from the spinal
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cord19. This indicates that our results are comparable to previous publications, despite limitations
such as interobserver variability and difficulty delineating soft tissue structures on CBCT.
During validation, a limitation of our algorithm was identified, as the algorithm was
unable to generate acceptable registrations when presented with extreme image artifacts caused
by high density implants. An attempt to mask out the artifact so the registration would ignore it
was unsuccessful. This may be due to the nature of the registration algorithm. Further work
could focus on making the method more robust to artifacts by testing different reconstruction
algorithms and masking methods. In its current state, the registration method is a viable option
for dose calculation mid-treatment course to inform resimulating and replanning decisions.
Patient with artifacts were excluded from this study.
Conclusions
DIR can be a useful tool for ART and related research. However, commercially available
DIR software is expensive and may not offer the flexibility needed for specific tasks. This study
used an open-source algorithm to address problems deforming pCTs to CBCTs. The resulting
deformations are useful for dose calculation at multiple timepoints over the course of a patient’s
treatment.
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